leaders impacting the life-sciences industry

Transcription

leaders impacting the life-sciences industry
Celebration
Inspired By
LEADERS IMPACTING
THE LIFE-SCIENCES INDUSTRY
September 17, 2015
PHARMAVOICE 100 CELEBRATION
1
Celebrating Innovation
and Inspiration in the
Life Sciences
Congratulations to this year’s PharmaVOICE 100 honorees,
including our own Kara Dennis and Steve Smith!
We commend PharmaVOICE for showcasing the outstanding
work of industry thought leaders for over a decade. Thank you
for fostering collaboration across the life sciences and for
sharing innovative ideas and insights that are moving our
industry forward.
Steve Smith
Chief Patient Advocate
[email protected] | mdsol.com | +1 866 515 6044
Kara Dennis
Managing Director of mHealth
Celebration
WELCOME LETTER
T
he idea behind
PharmaVOICE — both
magazine and online — created a
forum for leaders to Read. Think.
Participate. in the dynamic life-sciences
industry. From molecule to market,
PharmaVOICE has been providing the
perspectives and insights of passionate
and committed thought leaders for
nearly 15 years.
On the way to an industry trade
show, about three years after the
launch of PharmaVOICE, we were
stuck in the Philadelphia airport.
During what turned into a very, very
long delay, we began talking about the
people who we were scheduled to meet,
how inspired we were by the work they
were doing, and the difference they
were making in the industry. Like the
start of so many great innovations, one
brainstorming idea led to another, and
upon landing at our destination the
following morning, we had also landed
on the concept of the PharmaVOICE
100.
So with an idea that started with
a special publication that long ago
August to celebrate the individuals
behind the companies, products,
brands, tools, and services that benefit
patients worldwide, we have now
recognized more than 1,000 of the
industry’s most inspirational leaders
from all sectors of the industry.
We view ourselves as a convener
— as evidenced by the tagline of our
publication: The Forum for the Industry Executive
— which is why this inaugural Celebration event is so
special and exciting. We have the opportunity to bring
together and recognize in person the men and women
— the PharmaVOICE 100 and Red Jacket honorees —
who are impacting change throughout the life-sciences
industry and who inspire so many people every day.
We have enjoyed getting to know each and every one
of the honorees over the years, and we look forward to
Taren Grom
their inspired leadership for years to come.
Editor, PharmaVOICE
On behalf of everyone at PharmaVOICE, I want to
thank all of our generous sponsors and attendees who made this event possible.
We are proud to donate a portion of the proceeds from the event to
Reach Out And Read, which prepares America’s youngest children to succeed in
school by partnering with doctors to prescribe books and encourage families to
read together.
TABLE OF CONTENTS
Letter from the Editor ............................................................................3
Agenda ....................................................................................................... 4
Executive Forum Panelists ...................................................................5
Table Curators ...........................................................................................6
Red Jacket Honorees — 2014 & 2015................................................8
PharmaVOICE 100 Celebration Sponsors ....................................10
Art of Inspiration .................................................................................... 16
Building Inspired Teams ..................................................................... 24
Inspiring Words.......................................................................................30
Inspiring Reads....................................................................................... 32
Inspiring Jobs.......................................................................................... 33
Inspired to Give....................................................................................... 34
PharmaVOICE 100 Honorees Through the Years...................... 36
PHARMAVOICE 100 CELEBRATION
3
Celebration
AGENDA
September 17, 2015
Apella Event Space • Riverpark, a Tom Colicchio Restaurant
The Alexandria Center for Life Science
TIME
EVENT
6:00 pm
Registration Opens
6:30 pm – 7:30 pm
Executive Forum
7:30 pm – 10:30 pm
Networking Event
8:00 pm – 8:30 pm
Curated Table Discussions
feel
FEEL DEEPER. We have a lot of heart for what patients and customers go through when it comes
to their healthcare. How do we know how they feel? We dig deep to find out. We engage with them
honestly and through real connections we uncover how they feel inside. Their fears, concerns,
and sometimes complete disconnection from their own health. Deep down in their hearts patients
want to feel that healthcare companies and providers “get them.” Sometimes brand promotion
and cool tactics aren’t enough. For clients looking to find new ways to engage customers, we also
create unique content to help them connect with their customers on a more meaningful level.
INFINITELY IN
Are you interested in a
heart-to-heart conversation
with your customers?
Call Matt Brown at
201-740-6160.
www.guidemarkhealth.com
Celebration
EXECUTIVE FORUM PANELISTS
JEFFREY S. ARONIN
Chairman & CEO, Marathon Pharmaceuticals
Mr. Aronin is a business leader, life-science investor, and philanthropist. He is also chairman and CEO of
Paragon Pharmaceutical Capital. Before founding Marathon, he founded Ovation Pharmaceuticals Inc.
and MATTER, a successful healthcare technology incubator to support entrepreneurs. Mr. Aronin was
named a PharmaVOICE 100 honoree in 2005, 2008, and a Red Jacket honoree in 2015.
DEBORAH DUNSIRE, M.D.
President and CEO, FORUM Pharmaceuticals
Dr. Dunsire has more than 25 years of scientific, clinical, operational, and commercial experience, as well
as proven leadership in the biotech and pharma industries. Before joining FORUM in 2013, she served
as President and CEO of Millennium Pharmaceuticals (now Takeda Oncology) from 2005 to 2013. Dr.
Dunsire was named a PharmaVOICE 100 in 2010 and 2014 and a Red Jacket honoree in 2015.
RICK KEEFER
Global Chief Business Development Officer, Publicis Healthcare Communications
Group
Mr. Keefer is a 30-year industry veteran with broad-based experience in leading commercial operations.
He was named Global Chief Business Development Officer of PHCG in January 2015. He was named a
PharmaVOICE 100 in 2008, 2009, 2010, 2011, 2012, 2013, and a Red Jacket honoree in 2014.
LEEROM SEGAL
Co-Founder & CEO, Klick Health
Mr. Segal is Co-founder and CEO of Klick Health, the world’s largest independent health agency. He is
also co-author of the New York Times bestseller The Decoded Company: Know Your People Better Than
You Know Your Customers. Mr. Segal was named a PharmaVOICE 100 honoree in 2012, 2013, 2014,
and a Red Jacket honoree in 2015.
CHRISTI SHAW
US Country Head, President, Novartis Corp. & Novartis Pharmaceuticals Corp.
Ms. Shaw has oversight responsibility for 27,000 associates over six divisions, for whom “More Moments
for More Memories” isn’t just a mantra — it’s a mission. Through the lens of innovation, integrity, and
inclusion, she leads the US General Medicines business and Novartis Corporation operations. Ms. Shaw
was named a PharmaVOICE 100 honoree in 2015.
PHARMAVOICE 100 CELEBRATION
5
Celebration
TABLE CURATORS
LAURIE COOKE, RPH
CEO, Healthcare Businesswomen’s Association
Ms. Cooke, a senior healthcare industry executive with an extensive career in both pharmaceutical
and nonprofit arenas, assumed the role of CEO of the HBA nine years ago. She is well-versed in
commercializing insights across the career continuum and drug development from preclinical to post
approval. Ms. Cooke was named a PharmaVOICE 100 in 2009.
DENISE DEMAN
Founder, Chairman & CEO, Bench International
With an indefatigable entrepreneurial spirit, Ms. DeMan has taken Bench International from its
founding in 1974 to its eminence today as the premiere specialized retained executive search firm focused
on life-sciences in the world. She is deeply committed to properly “shattering” the glass ceiling for
women in the life-sciences. Ms. DeMan was named a PharmaVOICE 100 in 2009.
CHRISTINE PIERRE
CEO and Founder, RxTrials Inc. and Founder and President, Society for Clinical
Research Sites (SCRS)
Ms. Pierre is internationally known for her experience and expertise in clinical research site management
and patient recruitment and retention for the clinical trials industry. Ms. Pierre was named a
PharmaVOICE 100 in 2009 and 2013.
STEPHEN SMITH
Chief Patient Advocate, Medidata Solutions
Mr. Smith was named chief patient advocate of Medidata Solutions in 2015. He is a staunch advocate for
rare disease patients and plays a unique and critical role in the modernization of the clinical trials process,
and serves on the Committee on Federal Legislation for the National MPS Society. Mr. Smith was named
a PharmaVOICE 100 in 2015.
CECI ZAK
Chief Operating Officer, Healthcare, DAS-Omnicom
Ceci Zak, who before joining DAS-Omnicom in 2013, spent more than 20 years with Sanofi and Roche,
most recently in GM roles, where she drove innovative culture and commercial model change while
exceeding targets and strategically positioning these companies for the future. Ms. Zak was named a
PharmaVOICE 100 in 2006 and 2015.
6
PHARMAVOICE 100 CELEBRATION
If the odds of lightening striking the same place twice are extraordinary, try three.
Congratualtions to our own Michelle Keefe, Matt McNally and Bill Drummy
for being honored among the PharmaVOICE 100 most inspiring people.
It’s an honor to work beside you.
Celebration
RED JACKET HONOREES — 2014 & 2015
JEFFREY BERKOWITZ
JEFFREY ARONIN
Member, Board of Directors
Infinity Pharmaceuticals
2014 Red Jacket Honoree
Chairman, CEO, Founder
Marathon Phramaceuticals
2015 Red Jacket Honoree
Inspired By
Inspired By
NICK COLUCCI
DEBORAH DUNSIRE, M.D.
CEO
Publicis Healthcare Communications Group
2014 Red Jacket Honoree
President and CEO
FORUM Pharmaceuticals
2015 Red Jacket Honoree
MAKING A DIFFERENCE
Inspired By
SURVIVAL
AMIR KALALI, M.D.
VP and Head of the Neuroscience
Center of Excellence
Quintiles
2014 Red Jacket Honoree
Inspired By
SCIENCE
Inspired By
PATIENTS
ALEX GORSKY
Chairman and CEO
Johnson & Johnson
2015 Red Jacket Honoree
Inspired By
PATIENTS
RICK KEEFER
FREDA LEWIS-HALL, M.D.
Global Chief Business Development Officer
Publicis Healthcare Communications Group
2014 Red Jacket Honoree
Chief Medical Officer and Executive VP
Pfizer
2015 Red Jacket Honoree
Inspired By
MAKING A DIFFERENCE
Inspired By
FAITH
DAVID ORMESHER
LEEROM SEGAL
CEO, President, and Co-Founder
closerlook, inc.
2014 Red Jacket Honoree
Co-Founder and CEO
Klick Health
2015 Red Jacket Honoree
Inspired By
PASSION
DONATO TRAMUTO
CEO and Chairman
Physicians Interactive
2014 Red Jacket Honoree
Inspired By
8
MAKING A CHANGE IN THE WORLD
SAVING LIVES
PHARMAVOICE 100 CELEBRATION
Inspired By
PATIENTS
Celebration
PHARMAVOICE 100 CELEBRATION SPONSORS
DIAMOND SPONSOR
Bench International is a retained,
performance milestone accountable Life
Science executive search firm, established
in 1974. We are One Global Team, No
Borders, No Boundaries, One Global
Budget, allowing us to focus exclusively
on our clients’ needs. Our 40 year scorecard:
• 98% retained searches successfully
completed
• 75% of candidates remain with same
company five years or longer with an
average of two promotions in five years
• Within 2-5 weeks of search launch
vetted candidates are delivered
• 90% of our clients are long-term client
partners.
Visit: benchinternational.com
solution taking shape, he connected
with businessman Tarek Sherif to start
a company that would focus solely on
advancing clinical testing. Today, Medidata
is the leading global provider of cloud-based
solutions for clinical research in life sciences,
transforming clinical development through
its advanced applications and intelligent
data analytics. Medidata is committed to
advancing the competitive and scientific
goals of global customers, which include over
90% of the top 25 global pharmaceutical
companies; innovative biotech, diagnostic
and device firms; leading academic medical
centers; and contract research organizations.
Visit: mdsol.com
Diego. Alexandria has a longstanding
and proven track record of providing
its client tenants with collaborative
environments that enhance
productivity and foster innovation.
Additional information, please visit:
are.com
inVentiv Health is a top-tier
professional services organization that
accelerates the clinical and commercial
success of biopharmaceutical
companies worldwide. Our combined
Clinical Research Organization
(CRO) and Contract Commercial
Organization (CCO) help clients
improve their performance to deliver
much-needed therapies to market.
With 14,000 employees providing
services to clients in 70 countries,
PLATINUM SPONSOR
The Medidata journey started in 1999
when a lab scientist, founder Glen de
Vries, looked for a way to make clinical
trials run better. With a SaaS technology
GOLD SPONSORS
Alexandria Real Estate Equities, Inc.
(NYSE:ARE) is the largest and leading
office REIT uniquely focused on
collaborative science and technology
campuses in urban innovation
clusters, including Greater Boston,
San Francisco, New York City, San
10
PHARMAVOICE 100 CELEBRATION
At inVentiv Health, we
combine the best
strategic brains in the
biopharmaceutical
industry with passion,
drive and endless
energy to help bring your
product from lab to life.
Please join us in congratulating
three exemplary individuals on
their inclusion in the PharmaVOICE
100 Most Inspiring People.
Kim Johnson, President
PALIO
Mike Menta, Chief Operating Officer
Campbell Alliance
Jeanine O’Kane, Managing Director
Biosector 2
inVentivHealth.com
Celebration
PHARMAVOICE 100 CELEBRATION SPONSORS
GOLD SPONSORS
inVentiv Health designs best practices,
processes and systems to enable clients
to successfully navigate an increasingly
complex environment.
Visit: inventivhealth.com
The Janssen Pharmaceutical Companies
of Johnson & Johnson are dedicated
to addressing and solving some of the
most important unmet medical needs in
oncology, immunology, neuroscience,
infectious diseases and vaccines, and
cardiovascular and metabolic diseases.
We bring innovative products, services
and solutions to people throughout the
world. Our research and development
strategy focuses on identifying medical
needs, and harnessing the best science
in the world, whether from our own
laboratories, or through strategic
relationships and collaborations.
Visit: janssen.com
advertising and promotion.
Visit: ochww.com
Ogilvy CommonHealth Worldwide—
the health behavior change specialists
of Ogilvy & Mather—committed to
creativity and effectiveness in healthcare
communications, everywhere. OCHWW
provides marketing services including
behavioral insights, content strategy and
management, digital, interactive and
new media services, marketing analytics
and research, media planning, medical
education, payer marketing and market
access, professional advertising and
promotion, public relations, relationship
marketing, social media and social
listening, and wellness and consumer
Publicis Healthcare Communications
Group (PHCG) is the largest healthoriented agency network in the world.
A division of Publicis Groupe, PHCG
manages top-tier agencies specializing
in promoting innovative solutions in
advertising, digital, branding, message
delivery, market access, and medical
communications. PHCG’s brands are
Saatchi & Saatchi Health, Digitas Health
LifeBrands, Publicis Life Brands, Razorfish
Health, Heartbeat Ideas, Discovery, insync Customer Insights, Publicis Health
Media, Publicis Touchpoint Solutions,
beacon healthcare, Maxcess, and Verilogue.
Visit: publicishealthcare.com
that does everything on a deeper level.
It starts with digging deeper to uncover
hidden truths that lead them to a
more honest engagement with patients
and customers. Then, from branding
and advertising to social media and
e-learning, they design and tailor tactics
to help people learn about their clients’
messages in their own unique way. It’s
not an approach you see every day.
With Guidemark Health, be ready for a
deeper engagement with your customers,
your patients and your agency. Visit:
guidemarkhealth.com
SILVER SPONSORS
Guidemark Health is a new breed of
agency. Guidemark Health is an agency
12
PHARMAVOICE 100 CELEBRATION
T
he power of our thinking
compels you.
Ready to cast out the conventional? Contact Shaun Urban at 973.352.1000
Celebration
PHARMAVOICE 100 CELEBRATION SPONSORS
SILVER SPONSORS
Reltio Cloud delivers reliable data,
relevant insights and recommended
actions so companies can be right
faster. Companies rely on Reltio
data-driven applications and
modern data management for better
planning, customer engagement and
risk management. Visit: reltio.com
Target Health Inc. is a New York City
based full service e*CRO dedicated
to all aspects of Regulatory
Affairs, Clinical Research,
Biostatistics, Data Management,
Internet-Based Clinical Trials,
Software Development, Strategic
Planning and Drug and Device
Development. Target Health
is committed, through creative
collaboration, to serve the
pharmaceutical community with
knowledge, experience,
technology and connectivity.
Our pledge is to optimize the
life cycle of drugs, biologics and
devices with expertise, leadership,
innovation and teamwork.
Visit: targethealth.com
UBC leads the market in providing
integrated, comprehensive clinical,
safety, and commercialization services.
UBC brings together renowned
scientific research and operations experts
with leading-edge technologies, allowing
for the best patient and healthcare
provider experience. Comprehensive,
end-to-end services cover product and
patient population characterization
during development and market
entry, as well as a focus on the patient
experience, safety, and adherence.
Visit: ubc.com
BRONZE SPONSORS
AmerisourceBergen is a global
healthcare solutions leader that drives
innovative partnerships with health
systems, manufacturers, providers
and pharmacies to improve product
access and efficiency throughout
the healthcare continuum.
AmerisourceBergen shapes healthcare
delivery through a range of services
and solutions including clinical trial
14
support, commercialization, global
sourcing and distribution, business
and practice management
consulting and patient support
services. Learn more about
these end-to-end solutions at
AmerisourceBergen.com.
Sunovion Pharmaceuticals Inc. is
dedicated to discovering, developing and
PHARMAVOICE 100 CELEBRATION
commercializing scientifically advanced
therapeutic products that are focused on
helping patients suffering from central
nervous system and respiratory disorders,
as well as other illness. The company
name, which is representative of the
life-affirming energy of the sun and the
power of innovation, reflects Sunovion’s
portfolio of currently marketed
pharmaceutical products and pipeline
candidates; and serves to emphasize the
company’s ongoing commitment to
improve the lives of patients everywhere.
Visit: sunovion.com
Celebration
THE ART OF INSPIRATION
MATT
GIEGERICH
Chairman & CEO
Ogilvy CommonHealth
Worldwide
2005
“Ultimately our
business is about
people. I am responsible
not only for the global
success of Ogilvy
CommonHealth
Worldwide but also
people’s personal
success.”
- Matt Giegerich
“The knowledge that
what I do, the decisions
that I make, and how I
innovate can translate
into new therapeutics
that will help people
with serious illnesses is
truly motivating.”
- William Strohl
WILLIAM STROHL
VP and Head,
Janssen
BioTherapeutics
Janssen R&D,
Johnson & Johnson
2015
“I continue to dedicate my career
to improving the clinical research
process and meeting the increasing
demands of the industry.”
- Lisa La Luna
LISA
LA LUNA
Senior VP, Business
Development,
ePharmaSolutions,
a WIRB-Copernicus
Group Company
2007
MERYL ZAUSNER
Executive VP,
Novartis
2014
RAKESH DIXIT
VP, R&D, Toxicology
MedImmune
2015
16
“We empower our employees to push the
boundaries of what’s possible to
advance science and the development
of life-changing medicines.”
- Rakesh Dixit
PHARMAVOICE 100 CELEBRATION
Celebration
“As consumers become
more sophisticated,
driven somewhat by
their engagement with
digital and social
media, the industry
has to innovate
in kind.”
- Asaf Evenhaim
ASAF EVENHAIM
CEO, Crossix
2012
“I am inspired by people who are
willing to roll up their sleeves, open
their hearts, and make the world a more
compassionate environment.”
- Lelia O’Connor
LELIA O’CONNER
RYAN SAADI, M.D.
Global Market Access &
Policy Leader, Oncology,
Janssen Research &
Development LLC
2011, 2015
“I try to always pull the discussion around
to the core question: how do we get
patients the access they need to innovative
therapies?” - Ryan Saadi
President
Ngal So Authentic
Leadership Group
2008
ELAINE RIDDELL
“I tell people no matter who you
are, where you work, or what you
do, you have an impact on saving
people’s lives and that inspires me
every day.” - Meryl Zausner
CEO
DECISIO LLC
2008
“The leaders of
tomorrow will be
those who learn to
collaborate with their
stakeholders, not just
‘sell’ to them.”
- Elaine Riddell
PHARMAVOICE 100 CELEBRATION
17
Celebration
THE ART OF INSPIRATION
OSNAT BENSHOSHAN
“To innovate or encourage others
to do so, one must inspire an intense
desire to simply do it better, preceded
by a deep understanding of how
things are currently done.”
- Osnat Benshoshan
Chief Marketing Officer,
SERMO
2015
“With leadership comes accountability
and responsibility to all those who
view you as a leader.”
- Dr. Theodore Search
“It’s about
empowering and
enabling genius
while having fun
along the way.”
- Melinda Richter
MARC SIROCKMAN
Executive VP, General
Manager, Artcraft Health
2015
DR. THEODORE SEARCH
CEO, Skipta
2015
MARYELLEN ROYLE
“The best we
can do as team
leaders is provide
and maintain a
supportive work
culture that allows
talent to grow
and thrive.”
- Maryellen Royle
18
President, North
America, Tonic Life
Communications
2015
PHARMAVOICE 100 CELEBRATION
“Our goal is to help patients make
informed decisions so that they can
help themselves with making the
right choice for their disease state and
where they are in their healthcare
continuum.”- Marc Sirockman
Celebration
MELINDA RICHTER
Head, Johnson &
Johnson Innovation
JLABS
2015
“I believe that to
be successful in any
endeavor, passion
keeps you focused
and persistent.”
- Neill Walsdorf
“I love to take something
and make it better, it’s
my passion in life and
something I get the most
personal satisfaction from.”
- Nicole Woodland-DeVan
NEILL “GOBIE”
WALSDORF
President, Mission
Pharmacal Company
2015
NICOLE WOODLAND-DEVAN
Senior VP, Buying Services &
Deliverables, Compas Inc.
2015
“As a leader you need to be
supportive and create an
environment where people
are willing to try something
new.” - Melissa Easy
LISS EASY
Founder of DrugDev
and President,
DrugDev SiteStart
2015
REMO COLARUSSO
VP, Manufacturing and
Technical Operations,
Janssen Supply Chain,
Janssen Pharmaceuticals
2015
“I set an expectation that we all innovate
in each of our jobs; every job is two-fold
— do the job and figure out a way to do
it better.” - Remo Colarusso
PHARMAVOICE 100 CELEBRATION
19
Celebration
THE ART OF INSPIRATION
MATT BROWN CEO
Guidemark Health
2014
MIKE MENTA
Chief Operating Officer
Campbell Alliance,
an inVentiv Health
company
2015
“There is nothing that
inspires me more than
to have the ability to
work with a talented
group of people and
be challenged daily in
an industry I love.”
- Mike Menta
ILYSSA LEVINS
President and Founder,
Center for Communication
Compliance
2012
“The biggest highlight to me has been
seeing people I have mentored go on to do
great things and achieve their goals.”
- Matt Brown
“I am committed and passionate about
the causes I feel strongly about, including
advancing therapies for people born with
rare diseases and by having more diversity in
the workforce.”- Wendy White
WENDY WHITE
VP, Rare Disease
Dohmen Life Science Services
2012, 2015
20
“I am inspired by connecting individuals
and organizations that have the capacity to
multiply each other’s impact.”
- Eve Dryer
PHARMAVOICE 100 CELEBRATION
“I actively mentor
because it’s critical to
have someone who
you can trust and ask
the question, ‘how
did I do?’ and know
they will answer you
honestly.”
- Ilyssa Levins
EVE DRYER
President
Eve Dryer Healthcare
Consulting
2007, 2015
ENTERPRISE
STRATEGY
IT’S IN OUR
GENOME
IT’S WHAT WE WERE BORN TO DO
Redefining what marketing means to pharma.
Creating engagements with value and purpose.
Leading integrated services with our digital DNA.
SEO
MULTICHANNEL
When you’re born to do something, it comes naturally.
Realize your potential with integrated services
from Intouch Solutions.
INTOUCHSOL.COM/GENOME
MEDIA
MOBILE
SOCIAL
CRM
DATA & ANALYTICS
CONSULTING
HCP + CONSUMER
CREATIVE
Celebration
THE ART OF INSPIRATION
STEPHEN SMITH
Chief Patient Advocate,
Medidata
2015
“I believe in a
cross-stakeholder
approach to
modernizing drug
development to
increase the number
of cures for serious
and life-threatening
disorders.”
- Stephen Smith
“I am moved by the
talent, passion, and
conviction of women
who are committed to
furthering the HBA’s
mission today and
fueling our aspirations
for the future.”
- Laurie Cooke
LAURIE COOKE
CEO, Healthcare
Businesswomen’s
Association
2009
CECI ZAK
“I believe the more you share, the
more you give; the more you do, the
wealthier you will always be.”
- Denise DeMan
Chief Operating
Officer for
Healthcare,
DAS-Omnicom
2006, 2015
“Mentoring is very important to me,
because there is no greater gratification
in anything I do than to help others
dream dreams and realize them.”
- Ceci Zak
DENISE DEMAN
Founder, Chairman, CEO
Bench
International
2015
“Be aware of everything you do
that has your name attached to
it.”- Christine Pierre
22
PHARMAVOICE 100 CELEBRATION
CHRISTINE PIERRE
CEO and Founder, RxTrials Inc. and Founder
and President, Society for Clinical Research
Sites (SCRS)
2009, 2013
am honored
Congratulations to
the PharmaVOICE 100
Class of 2015
We’re proud to
see our leaders
recognized for
another year
running
Our therapeutic
depth creates strong
connections with both
sponsors and sites
So that patients
worldwide can get
the medicines they
need, sooner
Congratulations to Alan Ong and Michael Gibertini
for being named in this year’s PharmaVOICE 100.
We are proud of all our talented staff whose
therapeutic expertise gives us our unique focus
and depth. To learn more about how our work helps
connect you to stronger clinical development programs,
visit incresearch.com
Celebration
BUILDING INSPIRED TEAMS
E
xecutives who boldly transform their company’s talent operations to be as innovative as their business
strategy see dramatic, measurable improvements in their company’s performance and ability to accelerate
growth, according to a recent report from PwC.
Inspired Results
fiercer than ever, the time
for talent innovation is now.
By viewing their people as assets on
Innovating a talent strategy
their balance sheet, and by aligning
to fuel business priorities
business goals with the talent strategy
can drive measurable
needed to achieve them, companies can
performance gains at every
see 75% higher revenue growth, 77%
stage of execution, including:
better strategy implementation, and
• 70% improved process
85% stronger financial performance
turnaround times
overall, according to PwC’s Project
• 30+% lower turnover
Management Institute, Talent
• 20% improved
Management - State of the Market
productivity
report. They also attract and retain
•
15-25%
HR operations
employees not just as bright new hires
savings
but as future leaders.
Deborah Dunsire, M.D., CEO,
•
30%
uptick in innovation
Talent innovation rethinks and
FORUM Pharmaceuticals
ideas.
transforms previously siloed processes
2010, 2014, and 2015 Red Jacket
As
part
of
PwC’s
annual
into a unified talent ecosystem,
how the digital world is changing the
CEO survey, results show a definitive
integrating designs to create a whole
workplace. But business leaders are
shift
in
the
level
of
concern
among
greater than the sum of each part,
also looking for adaptable people —
business leaders worldwide over the
ultimately built to advance a company’s
talent with a wide range of skills and
impact of skills shortages on their
business strategy, accelerate business
the willingness to keep learning and
business, in spite of a market increase
performance, and cultivate a modern
apply what they know wherever and
in business confidence. Three-quarters
workforce that’s diverse, engaged, and
whenever they’re needed.
of all CEOs ranked it as the biggest
delivering on its goals.
PwC analysts say what is clear is that
threat to growth — a 10% jump from
With today’s ever-shifting market
organizations can’t rely on recruiting
last year and a 46% increase from six
forces and the battle for talent proving
people as they’ve always done in the
years ago.
past — they need to look in new
The survey also found
“As a leader if you don’t develop
places, geographies, and from new or
that
people
with
strong
the next level of leadership, you
alternative pools of talent. In other
technology skills are
are putting your company’s future
words, companies have to think outside
particularly
sought
at risk.” — Dr. Deborah Dunsire
the box.
after — an indication of
[
]
24
PHARMAVOICE 100 CELEBRATION
Celebration
know they can be.
Mr. Gallo outlines
seven qualities that he
says all inspiring leaders
share: ignite enthusiasm,
navigate a course of
action, sell the benefit,
paint a picture, invite
participation, reinforce
optimisim, and encourage
potential.
In a recent Harvard
Jeff Aronin, Founder, Chairman, CEO
Business Review article,
Marathon Pharmaceuticals
Jack Zenger and Joseph
2005, 2008, and 2015 Red Jacket
Folkman discussed
what top executives want from their
leaders (see side bar). They report
that according to an IBM survey of
Carmine Gallo, a columnist for Forbes,
1,700 CEOs in 64 countries, the three
wrote recently that one-third of U.S
leadership traits that most mattered
employees are so unhappy they are
were the ability to focus intensely
thinking of leaving their jobs. He poses
on customer needs, the
ability to collaborate with
“I offer the freedom for people
colleagues, and the ability
to be creative and make mistakes
to inspire.
and I set a bold vision to align
These experts also
the team.” — Jeff Aronin
turned their attention to
the
question
of whether leaders could
the question: how is it possible that
learn to become more inspiring. To
unhappy, unmotivated, and disengaged
find out they did another study of
employees could possibly offer
882 executives from data collected
exceptional customer service or develop
over the last three years, who were
exciting, innovative products that
measured on 16 different competencies
move your brand forward? Mr. Gallo
and encouraged to focus efforts on
responds they can’t, that’s why it’s up to
improving one of them. Focusing on
company leaders to satisfy what he says
the 310 who chose to improve their
is a person’s “chief want;” someone who
ability to inspire others they found that
will inspire employees to be what they
“Chief Want”
[ ]
INSPIRED
LEADERS
Of the 16 leadership
competencies Harvard
Business Review most
frequently measures, they
report that inspiration is
the one trait that stands
out. Their data reveal
that the ability to inspire
creates the highest levels
of employee engagement
and commitment. It is what
most powerfully separates
the most effective leaders
from the average and leasteffective leaders. How do
they do it? They set stretch
goals with their team. They
spend time developing
their subordinates.
They engage in highly
collaborative behavior.
They encourage those
around them to be more
innovative. They establish
a clear vision. They make
emotional connections.
PHARMAVOICE 100 CELEBRATION
25
Celebration
BUILDING INSPIRED TEAMS
[]
“What really resonates is
purpose tied to a deep
sense of mission.”
— Christi Shaw
Inspired Leadership
In the continually evolving lifesciences environment, leaders
need to keep an open mind, listen
carefully to their marketplaces,
Christi Shaw, US Country Head,
and understand the needs of
President, Novartis Corp. & Novartis
Pharmaceuticals Corp.
the patients their companies
2015
ultimately serve. Therefore, it is
as a group they made impressive
more important than ever for leaders
strides — moving from the 42nd
to inspire their team members to
percentile (that is, below average)
achieve their professional goals, thereby
to the 70th percentile. This is a
ensuring sustainable success for their
statistically significant positive
organizations.
gain, and compelling evidence that
“Talent development is a critical
when leaders use the right approach
component within my own company,”
they can learn to become more
says Deborah Dunsire, M.D., CEO,
inspiring.
FORUM Pharmaceuticals. “I believe
In other words, Mr. Zenger and Mr.
that as a leader if you don’t develop the
Folkman say with awareness, good
next generation of leadership, you are
putting your company’s future at risk.
feedback, and a plan of development,
It’s an absolutely critical business
leaders are able to improve this
priority
to ensure that you have a
most important of all leadership
pipeline of leaders in development all
competencies.
the time.”
When it comes
“Mentoring and focusing on people
to
her personal
development are really the most
inspirational
important things that I do.”
leadership style, Dr.
— Alex Gorsky
Dunsire says as a
[]
26
PHARMAVOICE 100 CELEBRATION
leader you don’t have to be
perfect, but each day, you
need to be better than you
were the day before and if
you keep doing that, you can
build greatness into people
and organizations.
For Jeffrey Aronin, founder,
CEO, and chairman of Marathon
Pharmaceuticals, inspired leadership is
about setting a vision.
“My leadership style is to hire very
talented people, put them in roles
where they are able to have creativity
and freedom, and clearly define the
mission so everybody is aligned,” he
says. “I like to think I offer a clear
vision as to where the company is
going. People know their role, but they
also recognize what everybody else
Alex Gorsky, Chairman and CEO
Johnson & Johnson
2010, 2014, and 2015 Red Jacket
Bring together and uncover relationships
across a vast amount of data to understand
markets, drive revenue and reduce risk through
actionable, real-time predictive insights.
Cloud-based Reltio data-driven applications
enable the management of key accounts,
affiliations, HCP/HCOs, products, plan and
payers, patients, key opinion leaders, clinical
trials and more.
Learn more at Reltio.com
iconic
With 30 years of experience, Tonic is the go-to
healthcare PR agency for both established
companies and ambitious start-ups.
contact
us
Maryellen Royle, President
+1 215 928 2368 | [email protected] | toniclc.com
Celebration
BUILDING INSPIRED TEAMS
[]
motivate your associates
so far with financial
incentives,” she says.
Ms. Shaw nurtures
an empowering culture
of “leading at all levels.”
She is known for her willingness
to continually challenge the status
quo. She’s also a firm advocate for
inclusiveness in the workplace. Ms.
Shaw empowers her associates to
speak up and encourages employee
engagement, as she understands that
an engaged workforce is critical to
helping patients and ensuring business
success.
Rick Keefer, global chief business
development officer, Publicis
Healthcare Communications Group,
says he is probably like many leaders,
“I obsess about making sure
that we bring the right people
into the right environment.”
— Leerom Segal
brilliant people. My belief is that
if a company can get the culture
right, it’s not just attractive to the
right individual, but it also creates
an environment where those
people thrive, and when people
are happy, they make your clients
happy, and when your clients
Leerom Segal, Co-Founder and CEO,
are happy, they reward you with
Klick Health
loyalty and growth. This is a very
2012, 2013, 2014 and 2015 Red Jacket
virtuous cycle that shapes our
is doing and we all hold each other
belief system. And of course, it’s easier
accountable.”
said than done to operationalize this
Leerom Segal, co-founder and CEO
type of model and takes a lot of work.”
of Klick Health and author of the bestAlong those same lines,
selling book The Decoded Company,
Christi Shaw, U.S. Country
believes that teams do amazing things
Head, president of Novartis
when they are inspired by challenges
Corp. and president of Novartis
that they believe in and when the right
Pharmaceuticals Corp., says what
team is in place.
really resonates with people is
“The most important thing we do
purpose tied to a deep sense of
as an organization is obsess about our
mission.
culture,” he says. “For the past 18 years,
“It’s easy to get caught up
we’ve been on a quest to figure out how
chasing the bottom line, but
to best build a center of gravity for
I’ve found that you can only
[]
“The team has always been the most
important piece of what I do. I surround myself
with really good, really passionate people.”
— Jeff Berkowitz
28
PHARMAVOICE 100 CELEBRATION
Jeff Berkowitz, Member, Board of Directors,
Infinity Pharmaceuticals
2009, 2010, 2012 and 2014 Red Jacket
Celebration
high standards, and I think it’s just
the opposite,” he says. “By creating an
environment where people feel that
they can be themselves, where they
can speak up and speak out, and at the
same time know that they’re going to
be challenged in an inspiring way, they
are willing to give their best, which
ultimately allows me to make the best
decisions.”
There are clearly discussions and
decisions that leaders make every day,
particularly in the space of healthcare,
that require an incredible amount of
rigor, focus,
and serious
“Whatever role you play or whatever area
deliberation,
you operate in, the ultimate goal is to
he says.
facilitate better healthcare for patients.”
“I think
— Rick Keefer
when the
balance is
right
—
an
inclusive
environment
communications or facilitate better
where people don’t feel that they
dialogues or increase the educational
need to walk on eggshells, where they
stream — helps facilitate better
can openly speak their minds, where
healthcare; I think this helps give
diverse opinions are welcome — I’m
people passion and a common goal.”
absolutely convinced that this ensures
Over the years, Alex Gorsky,
that all issues are brought into the
chairman and CEO of Johnson &
discussion, are considered, and that
Johnson, has found that developing
again, ultimately, the right decisions get
personal relationships while creating
made,” Mr. Gorsky says.
an informal environment — one still
Admittedly, he says this approach
held to high standards — engages and
requires a lot of active engagement, and
inspires people to do things that they
this is one of the natural dynamics of
wouldn’t think that they’re capable of
being a leader that can sometimes be
doing on their own.
intimidating.
“Sometimes, there’s the belief that a
Jeff Berkowitz, currently a board
leader can’t be informal and still have
in that he doesn’t view himself as
an inspirational leader, contrary to
popular opinon.
“I’m happy that people are able
to derive some inspiration from my
approach, which is that whatever role
you play or whatever area you operate
in, the ultimate goal is to facilitate
better healthcare for patients,” he
says. “I think I’ve always done a good
job of reminding people why we’re
in this industry and that what we
do — whether it’s developing a tool
that allows patients to access better
[]
Rick Keefer, Global Chief Business
Development, Publicis Healthcare
Communications Group
2008, 2009, 2010, 2011, 2012, 2013
and 2014 Red Jacket
member at Infinity Pharmaceuticals, is
focused on the team and team dynamics.
“For me the team has always been
the most important piece of what I do,”
he says. “I like to surround myself with
really good, really passionate people. I
also have to believe in what I’m doing,
I have to be passionate about it, and
this translates to those around me.
“From a people perspective, I have
been able to identify passionate and
smart people who I know can go well
beyond what it is that they’re doing
on a day-to-day basis,” Mr. Berkowitz
continues. “This is very motivating to
teams; they know that as long as they’re
doing good work and as long as they’re
challenging the status quo, there are
going to be opportunities for them
within the groups that I lead.”
PHARMAVOICE 100 CELEBRATION
29
Celebration
InspiringWORDS
FUN FACT
The
Golden Rule
Inspiration can come in many forms and from a
variety of sources. Our PharmaVOICE 100 have
provided us with some of their favorite axioms that
have guided them in their leadership journeys.
“Do not impose on
others what you do not
wish for yourself”
JEANNE ZUCKER , 2008
“The advancement of women worldwide through
programs designed to sponsor them, and help them
prepare for and assume leadership roles is now more
critical than ever.”
RON COHEN, 2009
“Live your life so
that, at the end,
your last thought
looking back is: that
was all right.”
“Your greatest
learnings in life
come from personal
experience.”
“Don’t wait for
anybody to tell you
what you need to do;
define yourself and
create your own unique
value.”
SHAUN URBAN, 2009
“Work hard,
and good things
will happen.”
LANCE CONVERSE , 2005
“How a leader handles challenges is key; it’s about
consistency in the approach, regardless how big or
small the issue: resolve the problem,figure out why it
became a problem in the first place, and ensure the
problem doesn’t recur.”
NICK COLUCCI 2006, 2010, 2013 and 2014 Red Jacket
“Curiosity contributes mightily to being
effective.”
30
ANN MOHAMADI, 2013
MICHAEL PARISI, 2012
ROBERT REBAK, 2011
“Do what really
interests you, not
what you are supposed
to do.”
CONFUCIUS 479BC
PHARMAVOICE 100 CELEBRATION
PETER KIRK, 2012
“Everything can always
be better.”
DRUG & DEVICE DEVELOPMENT
IS OUR BUSINESS
• FullServiceeCRO
• ExtensiveFDAInteractions
• BroadRangeofExperience
• Over35RegulatoryApprovalsWorldwide
CHAMPION OF THE PAPERLESS CLINICAL TRIAL
CONTACT:
Jules T. Mitchel, MBA, Ph.D.
President,TargetHealthInc.
261MadisonAvenue24thFloor
212-681-2100ext.0
[email protected]
www.targethealth.com
Celebration
InspiringREADS
From books that outline lessons in leadership to those
that define new business models, the PharmaVOICE
100 identify what’s hot on their reading lists.
Dr. Sandra Lottes, 2015
Lean In: Women, Work,
and the Will to Lead by
Sheryl Sandberg
FUN FACT
Printed Book vs. e-Book
First book mass
printed
1454
First e-reader
patent
1949
Michael Fergusson, 2012
Kim Johnson, 2015
Predictably Irrational: The
Hidden Forces That Shape
Our Decisions by Dan Ariely
What Got You Here Won’t
Get You There by Marshall
Goldsmith
Scott Plevy, M.D., 2015
Tom Hospodar, 2015
Faruk Capan, 2009, 2012
Scott Ballenger, 2007
Humble Inquiry: The Gentle
Art of Asking Instead of
Telling by Edgar H Schei
Collective Genius: The Art
and Practice of Leading
Innovation by Linda Hill
The Advantage: Why
Organizational Health Trumps
Everything Else In Business
by Patrick Lencioni
Seeing What’s Next: Using
Theories of Innovation to
Predict Industry Change by
Clayton Christensen
Bill Drummy, 2008, 2015
The Information: A History,
A Theory, A Flood by James
Gleick
32
Ric Cavieres, 2015
No Ordinary Disruption: The
Four Global Forces Breaking
All the Trends by Richard
Dobbs and James Manyika
PHARMAVOICE 100 CELEBRATION
Lisa Giles, 2015
Michelle Marlborough, 2014
Rocket Fuel: The One
Essential Combination That
Will Get You More of What
You Want from Your Business
by Gino Wickman and Mark
C. Winters
The Phoenix Project: A
Novel about IT, DevOps, and
Helping Your Business Win
by Gene Kim, Kevin Behr and
George Spafford
Celebration
“I would be a physician. I spend
so much time thinking about
therapies, I’ve gotten to
understand the power of
the medical profession.”
Inspring
Kara Dennis, 2015
JOBS
The PharmaVOICE 100 have chosen careers in
the life-sciences industry and they are passionate
about making a difference. Over the years, we’ve
asked our honorees if they could chose a second
profession, what might that be.
Darlene Dobry, 2011
“I’ve always had a passion
for writing;–I have so
many ideas in my head for
books or songs.”
Marc Weiner, 2013
“College professor - in my
idealistic world, education
would be as fulfilling
as working in the
healthcare space.”
Max Kanevsky, 2015
“Most college professors don’t
teach in a way that inspires
students to change the
world. I would like to
try it differently.”
Laura Liotta, 2015
“I would be a psychologist. I
find people, and what makes
them tick, fascinating.”
Jeanine O’Kane, 2015
“I would be a baker, and
create a memorable
experience for people.”
FUN FACT
Job YOU MIGHT NOT HAVE
KNOWN EXISTED
PHARMA
ARTISAN
One possible outcome of the
push for personalized medicine.
PHARMAVOICE 100 CELEBRATION
33
Celebration
InspiredTO GIVE
The PharmaVOICE 100 not only positively impact
their companies and their teams, they are
philanthropists who give generously of their time,
resources, and talents to organizations dedicated
to helping those in need.
FUN FACT
MOST Giving
Country
UNITED STATES and MYANMAR
are tied for the most giving country
Tina Fascetti, 2014
Liver Life Walk Organ transplant. Tina lost her
brother after two liver transplants due to infection, but
that doesn’t take away the fact it is the most amazing
gift a person and family can give. Additionally, her
best friend received a liver transplant and is thriving
because of the generosity of an amazing family who
Julie Kempf, 2009, 2013
Good Grief, which helps children and teens cope
with loss. Julie lost her mother to cancer when she
was 15, and working with Good
Grief has given her an opportunity
to create a legacy for her mom.
lost their child on Christmas Eve. She has
also gotten close to the transplant teams
of two teaching hospitals and have found
them to be truly amazing people in so many ways. The decisions they are
forced to make on a daily basis due to the lack of available organs and
their ability to perform such a complex surgery are nothing short of heroic.
Terry Herring, 2007, 2008
Big Brothers, Big Sisters
(BBBS); the Kirkwood Camp;
and a yearly Youth Mission Trip.
Vera Rulon, 2015
Stanley Woodland, 2008
Have A Chance Walk, a
program that provides support
for brain tumor research.
Founding member of Arts
Angels Inc., which supports
the arts in a public school
district.
Bill Drummy, 2008, 2015
Lynn O’Connor Vos, 2005
The Jed Foundation is the nation’s leading
organization that works to promote emotional
health and prevent suicide
among college and university
students.
The Hole in the Wall Gang
Camp and The National
Multiple Sclerosis Society
Charlotte Sibley, 2006
American Kidney Fund
Board of Trustees
34
PHARMAVOICE 100 CELEBRATION
Sunovion salutes
PharmaVOICE for a decade
of honoring the industry
and recognizing leadership
A proud sponsor of the PharmaVOICE 100
Celebration, Sunovion is a leading
pharmaceutical company dedicated to
discovering, developing and commercializing
therapeutic products that advance the science
of medicine in the psychiatry, neurology
and respiratory disease areas to improve the
lives of patients and their families.
Sunovion Pharmaceuticals Inc.
Visit us at www.sunovion.com
and connect with us on Twitter @Sunovion
and LinkedIn.
Shaping healthcare delivery takes past
experience and forward thinking. It takes
a global healthcare solutions leader.
ItTakesAmerisourceBergen.com
33684-15-264463_ABC_Hindsight_3.75x5_PV_4C_r1.indd 1
8/31/15 1:55 PM
Sunovion_Ad_PharmaVOICE100.indd 1
DIAMOND SPONSOR
PLATINUM SPONSOR
GOLD SPONSORS
SILVER SPONSORS
SILVER SPONSORS
Thank You!
8/31/15 11:19 A
Celebration
PHARMAVOICE 100 HONOREES
THROUGH THE YEARS
P
harmaVOICE is proud to have recognized more than 1,000 of the most inspiring, motivating, innovative leaders throughout the
life-sciences industry for more than decade. Their dedication to their companies, teams, and communities has had a positive ripple
effect on tens of thousands of individuals as well as the hundreds of thousands of patients who they ultimately serve. Please note,
honorees are listed with their company at the time of recognition; for multiple-time honorees, it is the company of the most recent honor.
A
Adrian Adams, Auxillium
Pharmaceuticals, 2012
Colleen Adams, Wyeth, 2009
Julian Adams, Ph.D., Infinity
Pharmaceuticals Inc.,
2008, 2011
Thomas Adams, Association of
Clinical Research Professionals,
2005
Jeffrey Adelglass, M.D., Research
Across America, 2014
Lisa Adler, Takeda Pharmaceuticals,
2014
Ann Aerts, M.D., Novartis AG, 2014
Michael Agard, Sanofi-Aventis, 2010
Gadi Aharoni, Ph.D., Algorithmic
Research Inc., 2006
Christopher Ahlberg, Ph.D., Spotfire,
2005
Mark J. Ahn, Ph.D., Hana Biosciences,
2005
Murray L. Aitken, IMS Health, 2005
Johanna Allston, Ph.D., bioCapture,
2010
Al Altomari, Barrier Therapeutics
Inc., 2007
Rich Altus, PDR Network, 2012
Carol Ammon, Endo Pharmaceuticals,
2006
Gaynor Anders, MMG, 2012
Diana Anderson, Ph.D., D.L. Anderson
International Inc, 2006
Karla Stricker Anderson, PwC, 2009
Randy Anderson, Ph.D., PPD, 2010
Vicente Anido Jr., Ph.D., ISTA
Pharmaceuticals, 2010
Kevin Aniskovich, Intelecare
Compliance Solutions Inc., 2008
Vaughn Anthony, D. Anderson &
Company, 2009
Elizabeth Izard Apelles, Greater Than
One Inc., 2009
Jason Appel, Sanofi-Aventis, 2008
Valdo Arnera, M.D., PHT Corp, 2008
Barry Arnold, M.B., B.Ch.,
AstraZeneca, 2005
Jeffrey S. Aronin, Ovation
Pharmaceuticals Inc., 2005, 2008,
and 2015 Red Jacket
Howard Asher, Life Sciences
Information Technology Global
Institute, 2005
36
Mara Aspinall, On-Q-ity, 2010
Ami Assayag, Specialty Diets, 2006
Ahsan Awan, PharmaLink, 2006,
2007, 2009, 2011
B
Lee Babiss, Ph.D., Roche, 2009, 2012
Joan F. Bachenheimer, BBK
Worldwide, 2005
William Bailey, Pharm.D., Daiichi
Sankyo Inc., 2007
John Bailye, Dendrite International,
2005
David Baker, Alcobra, Ltd., 2015
Dan Baker, Janssen Research &
Development, 2013
Matthew Baker, Compass IRB, 2011,
2012
Robert Baldini, Esprit Pharma, 2007
Frank Baldino Jr., Ph.D., Cephalon,
2007, 2011
Scott Ballenger, Trial Acceleration
Institute Inc, 2007
John Philip Bamforth, Ph.D., Eli Lilly
and Company, 2007
Mohan Bangalore, Ph.D., Pfizer, 2010
Mark Bard, Manhattan Research,
2006
Natalie Barndt, Cephalon, 2006
Jackie Barnes, Pfizer, 2006
Alain D. Baron, M.D., Ethos
Pharmaceuticals Inc., 2008
Jack Barrette, Yahoo Inc, 2005, 2006
Richie Bavasso, Exploria SPS, 2007
Donna Beardsworth, Beardsworth
Group, 2011
Michael Beckloff, Beckloff
Associates, 2009
Gary Beer, Independent Investment
Professional, 2009
Nancy Beesley, HCB Health, 2012
Ken Begasse Jr., Concentric
Healthcare, 2008
Christopher Begley, Hospira Inc., 2007
Dominic Behan, Ph.D., Arena
Pharmaceuticals, 2013
Christian Behrenbruch, Ph.D.,
ImaginAb, 2013
John Benbrook, MMG, 2006
Osnat Benshoshan, SERMO, 2015
Jeff Berg, Ph.D., AbelsonTaylor, 2014
Donna Berk, M.S., Target Research
Associates Inc., 2005
PHARMAVOICE 100 CELEBRATION
Jeffrey Berkowitz, Walgreens, 2009,
2010, 2012, and 2014 Red Jacket
Charlotte Berlin, Astellas Pharma
US, 2009
Stan Bernard, M.D., Bernard
Associates LLC, 2006
Michelle Berrey, MD, MPH, Chimerix,
2015
David Berry, Pronutria, 2013
Jay Bigelow, MicroMass
Communications, 2008
Glenn Bilawsky, i3, 2005, 2010
Howard Birndorf, Nanogen, 2007
Ross Bjella, DDN Pharmaceutical
Logistics, 2009
Stella Blackburn, Quintiles, 2015
Wendy Blackburn, Intouch Solutions,
2010
Jody Blakeway, athenahealth, 2013
Larry Blankstein, Ph.D., Genzyme, 2009
Paul Bleicher, M.D., Ph.D.,
PhaseForward, 2005
Andrew Blight, Ph.D., Acorda
Therapeutics Inc., 2011
Timothy Block, Ph.D., Pennsylvania
Biotechnology Center, 2011
Jeff Boatman, QPharma, 2010
Dan Bobear, Palio, 2010
Kim Boericke, Quintiles, 2012
Joseph Bolen, Ph.D., Millennium: The
Takeda Oncology Company, 2011
Jay Bolling, Roska Healthcare, 2010
Mark Booth, Takeda Pharmaceuticals
North America, 2006
Alexis Borisy, Warp Drive Bio, 2012
Susan Bornstein, eClinical Solutions,
2010
Jerome Boscia, M.D., Janssen
Research & Development, 2012
Debbie Botwick, Pfizer, 2009
Calep A. (Joe) Boyd III, MCS
Healthcare Public Relations, 2011
Joan Bradley, Pharm.D., The JB
Ashtin Group, 2009
Damian Braga, Sanofi Pasteur, 2013
Gregg Brandyberry, GlaxoSmithKline,
2008
Richard Branton, Merck, 2010
David Brennan, AstraZeneca, 2010
Philip Brennan, marketRx, 2005
Bonnie Brescia, BBK Worldwide, 2005
Bob Brooks, GlaxoSmithKline, 2006
Michael Brooks, PPD, 2014
Matt Brown, ICC Lowe, 2014
Jessica Brueggeman, MicroMass
Communications, 2013
David Bruggeman, Clinical Research
Advantage, 2013
Kurt Brykman, Parexel Consulting, 2006
Dyan Bryson, Inspired Health
Strategies, 2012
Thomas Buckley, StayinFront Inc.,
2006
Brendan Buckley, M.D., D.Phil.,
Firecrest Clinical, 2010
Graham Bunn, Ph.D., Medidata
Solutions Worldwide, 2010
Andrew Burns, WorldOne, 2013
Jonathan Bush, athenahealth, 2013
Jon Butko, MediciGlobal, 2008
Arif Butt, SelectScience, 2014
Calvin Butts, CMI Communications
Media Inc, 2013
Marc Buyse, IDDI, 2013
William Buzzeo, Cegedim Compliance
Solutions, 2011
Bill Byrom, Ph.D., ClinPhone, 2008
C
Jerry Cacciotti, Strategic Decisions
Group, 2006
John Campbell, Campbell Alliance
Group Inc., 2006
Rich Campbell, Regan Campbell Ward
McCann, 2007
Tom Campbell, Healthy Advice
Networks, 2010
Faruk Capan, Intouch Solutions Inc.,
2009, 2012
Judy Capano, Wishbone/ITP Inc.,
2009
Walter Capone, MMRF, 2013
Molly Carnes, M.D., University of
Wisconsin-Madison, 2014
Randall Carpenter, M.D., Seaside
Therapeutics, 2011
Daniel Carr, M.D., Innovative Drug
Delivery Systems, 2005
J. Martin Carroll, Boehringer
Ingelheim Pharmaceuticals Inc,
2012
Jay Carter, AbelsonTaylor, 2005, 2006
Kathleen Case, Columbia MedCom
Group Inc., 2006
Michael Castagna, Pharm.D., BristolMyers Squibb, 2011
Celebration
Kathleen Castore, Sanofi, 2012
Ric Cavieres, EY Advisory Life
Science, 2015
Marco Chacón, Ph.D., Paragon
Bioservices, 2012
Jaswinder Chadha, marketRx, a
Cognizant company, 2009
Jane Chin, Ph.D., Medical Science
Liaison Institute LLC, 2006
Bob Chandler, Chandler Chicco
Companies, 2014
T. G. Chandrashekhar, Ph.D., Ranbaxy
Research Laboratories, 2007
Dave Chapman, Ogilvy
CommonHealth, 2007
Scott Chappel, OvaScience, 2013
Olivier Chateau, GlaxoSmithKline, 2009
Will Cheung, Comprehend Systems,
2014
Simon Chin, Iris BioTechnologies Inc.,
2008
William Ciambrone, Shire Human
Genetic Therapies, 2010
William Clapper, MTI Information
Technologies LLC, 2006
Chad Clark, UBC, 2010
Cathryn Clary, M.D., Ipsen
Biopharmaceuticals, 2012
William Claypool, M.D., Phoenix Data
Systems Inc., 2006
Mary Clegg, SynteractHCR, 2013
Terri Clevenger, Continuum Health
Communications, 2012
John Cline, etrials Worldwide Inc.,
2005
Martine Clozel, M.D., Actelion
Pharmaceuticals Ltd., 2008
Jamie Cobb, MicroMass
Communications, 2010
Matthew Coffey, Ph.D., Oncolytics
Biotech Inc., 2007
Isaac Cohen, OMD, Bionovo, 2006
Jaime Cohen, TCN e-Systems LLC,
2008
Ron Cohen, M.D., Acorda
Therapeutics Inc., 2009
Remo Colarusso, Janssen
Pharmaceutical Companies of
Johnson & Johnson, 2015
N. Anthony Coles, M.D., Onyx
Pharmaceuticals, 2011
Francis Collins, M.D., Ph.D., NIH, 2013
Steve Collis, AmerisourceBergen,
2013
Nicholas Colucci, Publicis Healthcare
Communications, 2006, 2010, 2013
and 2014 Red Jacket
Peg Connelly, Kforce Clinical Research
Inc., 2009
Reid Connolly, evoke Interaction,
2011, 2014
Alyson Connor, MicroMass
Communications, 2011
Lance Converse, ePharmaLearning,
2005
Laurie Cooke, R.Ph., Healthcare
Businesswomen’s Association, 2009
Lynnette Cooke, Kantar Health, 2010
Grant Corbett, Behavior Change
Solutions, 2005
Nancy Corkum, Johnson & Johnson
Corp., 2009
Mark Corrigan, M.D., Sepracor, 2009
Brian Corvino, PharmaStrat Inc., 2008
Rob Cosinuke, Epocrates, an
athenahealth service, 2015
Lisa Costantino, EMD Serono, 2012
Santino Costanzo, Organogenesis Inc.,
2007, 2008
Anthony Costello, Nextrials Inc, 2006
Scott Cotherman, Corbett Accel
Healthcare, 2005
Carrie Cox, Schering-Plough Corp.,
2007
Teri Cox, Cox Communications, 2005
Rose Crane, Epocrates, 2010
Stanley T. Crooke, MD, PhD, Isis
Pharmaceuticals, 2015
William Crown, Ph.D., i3, 2006
Donna Cryer, CryerHealth, 2011
Sean Cunliffe, Neuromed
Pharmaceuticals, 2008
David Cunningham, TrialCard, 2014
Mark Cunningham, Janssen Research
& Development, 2014
Mark Curran, Ph.D., Janssen Research
& Development, 2013
Tyrone Curran, Harrison & Star, 2011
Jim Curtis, Remedy Health Media,
2013, 2014, 2015
Stephen Cutler, Ph.D., Kendle, 2011
D
Matthew D’Ambrosio, Sunovion
Pharmaceuticals, 2014
Bassil Dahiyat, Ph.D., Xencor Inc.,
2007
Joseph Daley, GSW, 2011
Susan Dallabrida, Ph.D., PHT, 2014
Patricia Daly, Metropolitan Research
Associates, 2005
Rich Daly, TAP Pharmaceuticals
Products Inc., 2006
Zubin Damania, M.D., Downtown
Project Las Vegas, 2013
Tim Davis, Exco InTouch, 2013
Yolanda Davis, Spaulding Clinical,
2011
Kate Dawson, M.D., Biogen Idec, 2014
Neil de Crescenzo, Oracle Health
Sciences, 2013
David de Graaf, Ph.D., Selventa, 2012
Stephan de la Motte, M.D.,
SynteractHCR, 2014
Jose De Leon, Daiichi Sankyo Inc.,
2008
Jonathan de Pass, M.B. Ch.B.,
Evaluate Ltd., 2014
Glen de Vries, Medidata Solutions
Worldwide, 2006
Jay Deakins, Deacom Inc., 2009
Gregg Dearhammer, i3 Statprobe,
2008, 2011
Jean-Francois Dehecq, SanofiAventis, 2007
Martine Dehlinger-Kremer,
SynteractHCR, Inc., 2015
Craig DeLarge, Novo Nordisk Inc.,
2007
Denise DeMan-Williams, Bench
International, 2009
Evan Demestihas, M.D., R.Ph.,
Science Oriented Solutions, 2006
Kara Dennis, Medidata Solutions, 2015
Barbara Deptula, Shire
Pharmaceuticals, 2007
Peter Derycz, Derycz Scientific, 2010
Camille DeSantis, Guard Dog Brand
Development LLC, 2008
Phil Deschamps, GSW, 2006
Susan Desmond-Hellmann, M.D.,
Genentech, 2006
Lucy Deus, SupplyScape Corp., 2009
Jack Devlin, AstraZeneca, 2007
Cheryl Dewey, Blue Chip Healthcare
Marketing, 2012
Punit Dhillon, OncoSec Medical Inc,
2013
Dan Diaz, SPRI Clinical Trials-Global,
2015
Peter DiBiaso, Pfizer Global Research
and Development, 2007
Sheng Ding, Ph.D., Fate Therapeutics,
2010
Gerianne Tringali DiPiano,
FemmePharma Global Healthcare
Inc., 2008
Michelle Dipp, M.D., Ph.D.,
GlaxoSmithKline, 2009
Rakesh Dixit, MedImmune, 2015
Darlene Dobry, Ogilvy CommonHealth,
2011
Brad Doerschuk, PharmaMed
Research, 2012
Daniel Donovan, Envision Pharma Inc,
2007, 2008
Susan Dorfman, Skila, 2008, 2009
Chris Downey, Genentech, 2005
Larry Downey, Teva Neuroscience,
2007
Joe Doyle, HCB Health, 2014
Tracy Doyle, Phoenix Group Holdings,
2006
Kathleen Drennan, Iris Global Clinical
Trial Solutions, 2008
Nancy Dreyer, MPH, Ph.D., Outcome,
2007, 2014
Jeffrey Drezner, M.D., Ph.D., Clinical
Care Options, 2007
Marty Driscoll, Reliant
Pharmaceuticals Inc., 2005
Glen Drummond, Gilead Sciences,
2009
Bill Drummy, Heartbeat Ideas &
Heartbeat West, 2015
Bill Drummy, Heartbeat Digital, 2008
Eve Dryer, Eve Dryer Healthcare
Consulting, 2007, 2015
Michael du Toit, Digitas Health
LifeBrands, 2014
Filipe Duarte, Merck & Co. Inc., 2008
Denise Duca, Acorda Therapeutics
Inc., 2013
Joanne Duckman, Torre Lazur
McCann, 2010
David Dunn, ApotheCom, 2010
Deborah Dunsire, M.D., Millennium:
The Takeda Oncology Co., 2010,
2014, and 2015 Red Jacket
Cameron Durrant, M.D., MBA, Anavex
Life Sciences, 2005, 2006, 2007,
2010
E
Melissa Easy, DrugDev, 2015
Lisa Ebert, Medicus Life Brands, 2010
Steven V. Edelman, M.D.,
Taking Control of Your Diabetes,
2008
Elliot Ehrich, M.D., Alkermes, 2012
Marianne Eisenmann, Chandler
Chicco Companies, 2012
Barry Eisenstein, M.D., Cubist
Pharmaceuticals Inc., 2007
Anders Ekblom, M.D., Ph.D.,D.D.S.,
AstraZeneca, 2005
Richard Elliott, Medical Marketing
Service Inc, 2006
Amy Ellis, MedAvante, 2013
Russell Ellison, M.D., FibroGen Inc,
2006
Doug Engfer, invivodata, 2005
David Epstein, Novartis, 2010
Dave Escalante, Cegedim, 2013
Dixie Esseltine, Takeda Oncology,
2015
Richie Etwaru, IMS Health, 2015
David Evans, Octagon Research
Solutions, 2006
Mary Hensley Evans, imc2 Health,
2009
Asaf Evenhaim, Crossix Solutions, 2012
F
John Farinacci, ResearchPoint, 2009
Tina Fascetti, PulseCX, 2014
Ali Fattaey, Ph.D., ACT Biotech Inc.,
2011
Michael Feehan, Ph.D., Observant
LLC, 2007
Bruce Feinberg, DO, Cardinal Health,
2015
PHARMAVOICE 100 CELEBRATION
37
Celebration
PHARMAVOICE 100 HONOREES
THROUGH THE YEARS
Lisa Fell, MediciGroup, 2007
Michael Fergusson, Ayogo Games,
2012
Prabhavathi Fernandes, Cempra
Pharmaceuticals, 2011
Karen Ferrante, M.D., Millennium:
The Takeda Oncology Company,
2012
Marc Ferrara, Jobson Medical
Information, 2008
Thomas Finn, The Procter & Gamble
Co., 2008
Fereydoun Firouz, Serono, 2006, 2008
Jennie Fischette, Concentric Health
Experience, 2014
Mark Fishman, M.D., Novartis, 2013
Tara Fitzgerald, INC Research, 2014
Sander Flaum, Flaum Idea Group,
2011
Aaron Fleishman, BBK Worldwide,
2014
Christina Fleming, Ph.D., Delta
Pharma, 2010
Candice Fliedner, Avid Bioservices
Inc., 2009
Frederick Foard, Communications
Media Inc., 2009
Marie Foegh, M.D., Agile
Therapeutics, 2012
Colleen Foley, Abbott, 2008
Robert Forrester, Verastem, 2014
Sonja Foster, Clinical Connexion, 2007
Tracy Foster, Lash Group, 2014
Edward Fotsch, M.D., PDR Network,
2011
Geoffrey Francis, Novozymes, 2009
Leo Francis, Ph.D., Publicis Medical
Education, 2010, 2012
Tim Frank, Triple Threat
Communications, 2014
Scott Freedman, Monitorforhire.com,
2005
Joy Frestedt, Frestedt Inc., 2011
Robert Friedman, M.D., InfoMedics,
2006
Patricia Furlong, Parent Project
Muscular Dystrophy, 2012
Barry Furr, Ph.D., AstraZeneca, 2006
G
Leslie Gaber, Leslie Gaber Associates,
2010
Erin Gainer, Ph.D., HRA Pharma, 2010
Christopher Gallen, M.D., Ph.D.,
Neuromed Pharmaceuticals, 2007
Kirk Gallion, Octagon Research
Solutions Inc., 2007
Richard Gams, M.D., Novella Clinical,
2014
Jean-Jacques Garaud, M.D., Roche,
2008
Timmy Garde, Star Group
Communications, 2012
38
Jud Gardner, Comprehend Systems,
2013
Philip Garland, BearingPoint Inc, 2008
Paula Garrett, Eli Lilly and Company,
2009
Peter Gassner, Veeva Systems, 2010
Joe Gattuso, MBS/Vox and
CommonHealth, 2006
Henry Gazay, Medimix International,
2011
Stephen Gerard, TGaS Advisors,
2008
Philip P. Gerbino, Pharm.D., University
of the Sciences in Philadelphia,
2005
Heather Gervais, Epocrates, an
athenahealth service, 2014
Daniel P. Getman, Ph.D., Pfizer, 2006
Kenneth Getz, Tufts Center for the
Study of Drug Development and
CISCRP, 2007
Melynda Geurts, D. Anderson &
Company, 2008
Daniel Ghinn, Creation Healthcare,
2014
Dr. Michael Gibertini, INC Research,
2015
Matt Giegerich, Ogilvy
CommonHealth, 2005
Lisa Giles, Giles & Associates
Consultancy / Optivara, 2015
Nancy Gillett, DVM, Ph.D., Charles
River Laboratories, 2006
Dennis Gillings, CBE, Ph.D., Quintiles,
2005
Steven Gilman, Ph.D., Cubist
Pharmaceuticals, 2009
Steven Girgenti, Ogilvy Healthworld,
2008
Kathy Giusti, The Multiple Myeloma
Research Foundation, 2009, 2014
John Glasspool, Novartis, 2014
George Glatcz, Vox Medica, 2009
Neil Gleghorn, Kallik Ltd, 2014
Richard Gliklich, M.D., Outcome, 2010
Kevin Glover, B. Braun Medical Inc.,
2007
Marcia Goddard, Torre Lazur McCann,
2009
William “Al” Godley, Edge Dynamics,
2007
Mark Goldberg, M.D., Perceptive
Informatics Inc, 2006
Linda Goldman, Inclinix, 2011
Peter Goldschmidt, Sandoz Inc, 2015
Dan Goldsmith, Veeva, 2014
Jennifer Goldsmith, Veeva Vault, 2011
Boris Golubtsov, M.D., Ph.D., Chiltern
International, 2005
Alex Gorsky, Johnson & Johnson,
2010, 2014, and 2015 Red Jacket
Ginger Graham, Amylin
Pharmaceuticals Inc., 2006
PHARMAVOICE 100 CELEBRATION
Susan Grant, Planning For Hope, 2013
Fabio Gratton, Ignite Health, 2009,
2014
Kelly Gratz, inVentiv Commercial
Solutions, 2012
Peter Gray, ICON, 2006
Mary Anne Greenberg, Alliance
Healthcare Information, 2011
Daniel Greenleaf, VioQuest
Pharmaceuticals, 2006
Janet Greeson, Ph.D., Samaritan
Pharmaceuticals, Inc, 2008
Sylvie Grégoire, Pharm.D., Shire
Human Genetic Therapies, 2011
Alberto Grignolo, Ph.D., Parexel
International, 2008
Kristin Gross, Acurian, 2013
John Guarino, Palio + Ignite, 2013
Adele Gulfo, AstraZeneca, 2007
Thomas Gunning, EMD Serono, 2009
Gene Guselli, InfoMedics Inc., 2007
H
Tuan Ha-Ngoc, AVEO Pharmaceuticals
Inc., 2009
David Hahn, The Medical Affairs
Company, 2013
Victoria Hale, Ph.D., Institute for
OneWorld Health, 2005
Nick Halkitis, MediciGlobal, 2010
Laurie Halloran, Halloran Consulting
Group, 2010
Steve Hamburg, Wishbone, 2010
Yusuf Hamied, Ph.D., Cipla Ltd., 2010
Mark Hanley, Clinical Research
Advantage, 2012
Karen Hanson, Ph.D., BioStrategy
Partners, 2009
Beth Harper, Centerphase Solutions
Inc., 2011
John Harrington, Sanofi-Aventis, 2008
Paul Harrington Jr., Palio + Ignite,
2014
Sarah Harrison, AstraZeneca, 2007
Michael Harte, etrials Worldwide
Inc., 2008
John Hartigan, MediciGroup Inc.,
2006
Shannon Hartley, Rosetta, 2012, 2014
Dan Hassan, Regan Campbell Ward
Group, 2010
Fred Hassan, Schering-Plough Corp.,
2009
Michael Hayden, Teva
Pharmaceuticals, 2015
Fran Heller, Exelixis, 2011
Maggie Helmig, Ogilvy Healthworld,
part of Ogilvy CommonHealth
Worldwide, 2015
Jean Hendrickson, Catalyst Clinical
Resourcing, 2014
Michael J. Hennessy, Intellisphere,
2006
Joseph Herring, Covance, 2005
Terrell Herring, inVentiv Health, 2007,
2008
Jamie Heywood, PatientsLikeMe,
2013
Raymond Hill, IMS Health, 2007
Maurice Hilleman, Ph.D., Merck, 2005
Kerry Hilton, HCB Health, 2013
Lyndi Hirsch, Genentech, 2009
Jeffrey Hoffman, Euro RSCG Life
Catapult, 2011
Bob Hogan, Triple Threat
Communications, 2015
Eduard Holdener, M.D., Roche, 2005
Louisa Holland, Sudler & Hennessey,
2005
Regina Holliday, The Walking Gallery
of Healthcare, 2014
Jane Hollingsworth, NuPathe Inc,
2008
Elizabeth Holmes, Theranos, 2015
Robert Holmes, Ph.D., Qforma, 2012
Tom Hospodar, Sunovion
Pharmaceuticals Inc., 2015
Leigh Householder, GSW, 2012
Keith Howells, Medidata Solutions
Worldwide, 2008
James Hoyes, EMD Serono, 2010
Patrick Hughes, CluePoints, 2015
Thomas Hughes, Ph.D., Zafgen Inc.,
2009
Dr. Franz Humer, Roche, 2006
William Humphries, Stiefel, a GSK
company, 2011
Nicole Hyland, Natrel, 2015
I
Edward Ikeguchi, M.D., Medidata
Solutions Worldwide, 2005
Diane Iler-Smith, Ogilvy Healthworld,
2014
Mike Innaurato, Purdue Pharma LP,
2012
J
Jonathan Isaacs, Evoke Health,
2014
Yuichi Iwaki, M.D., Ph.D.,
MediciNova, 2012
Paul Janssen, M.D., Ph.D., Janssen
Pharmaceutica, 2005
Lisa Jenkins, Ph.D., Virtual Regulatory
Solutions, 2015
Joe Jimenez, Novartis, 2010, 2011
Michael Jirousek, Ph.D., Catabasis
Pharmaceuticals, 2011
Greg Johnson, Strategic Business
Research, 2009
Kim Johnson, PALIO, 2015
Jeff Jonas, Shire, 2013
Ken Jones, Compas Inc. and CMI
Inc., 2007
Roger Jones, Ph.D., Qforma, 2011
Celebration
Deborah Jorn-Muthard, ScheringPlough Pharmaceuticals, 2006
K
John Kaiser, Acadia Pharmaceuticals
Inc, 2009
Amir Kalali, M.D., Quintiles, 2005,
2006, 2008, 2011, 2012, and 2014
Red Jacket
Clifford Kalb, Wood Mackenzie Inc.,
2005
Allison Kalloo, Clinical Ambassador,
2012
Joanne Kamens, Addgene, 2013
Julie Kampf, JBK Associates, 2009,
2013
Max Kanevsky, Pinnacle 21, 2015
Harris Kaplan, Healogix, 2011
Anjali Kataria, Conformia Software,
2005
Karen Katen, Pfizer, 2006
Jay Katz, Rockpointe Corp, 2008
Mitchell Katz, Ph.D., Purdue Pharma
LP, 2011
Michelle Keefe, Publicis Touchpoint
Solutions, 2014, 2015
Rick Keefer, Publicis Selling Solutions,
2008, 2009, 2010, 2011, 2012, 2013,
and 2014 Red Jacket
Greg Keenan, MD, Astra Zeneca,
2015
Bruce Kehr, M.D., InforMedix, 2007
Dennis Keith, Ph.D., Cubist
Pharmaceuticals Inc, 2008
Ken Keller, Amgen, 2007
Ian Kelly, Red Nucleus, 2012
Mike Kelly, Kantar Health, 2013
Candace Kendle, Pharm.D., Kendle,
2010
Kyle Kennedy, The Medical Affairs
Company, 2009
Nick Kenny, Ph.D., INC Research Inc.,
2008
Debbie Kenworthy, Ortho-McNeil
Janssen Pharmaceuticals,
2008
Iya Khalil, Ph.D., GNS Healthcare,
2014
Mehmood Khan, M.D., Takeda Global
Research and Development Center
Inc., 2007
Matt Kibby, BBK Worldwide, 2006
Marc Kikuchi, AmerisourceBergen,
2015
Jinsoo Kim, Image Solutions, 2005
Joseph Kim, Ph.D., Inovio
Pharmaceuticals, 2013
Deborah Jones King, Empatha Inc, 2006
Jennifer King, The Medical Affairs
Company, 2010
Rachel King, GlycoMimetics, 2013
Jeffrey Kingsley, D.O., SERRG Inc.,
2009
Peter Kirk, WorldOne, 2012
Linda Kitlinski, Endo Pharmaceuticals,
2008
Bob Klein, Blue Chip Healthcare
Marketing, 2013
Tami Klerr-Naivar, PRA, 2012
James Knipper, J. Knipper & Co. Inc.,
2009
Geert Kolvenbag M.D., Ph.D., F.F.P.M,
AstraZeneca, 2008
Roger Korman, Ph.D., DMD/Aptilon,
2012
Rob Kotin, Ph.D., Voyager
Therapeutics, 2014
Jeff Kozloff, Verilogue, 2010
Daniel Kraft, M.D., IntelliMedicine,
2013
Kevin Kruse, Axiom Professional
Health Learning, 2006
Ryo Kubota, M.D., Ph.D., Acucela,
2011
Kevin Kucharski, Achillion
Pharmaceuticals, Inc., 2015
Jeff Kueffer, INC Research, 2013
Vijai Kumar, M.D., Excel Life Sciences,
2010
Dale Kummerle, Pharm.D., BristolMyers Squibb, 2012
Rebecca Daniels Kush, Ph.D., CDISC,
2008
Boris Kushkuley, Intouch Solutions, 2015
L
Lisa La Luna, ePharmaSolutions, 2007
Mark Laabs, Rare Cancer Research
Foundation, 2014
Laurent Labrune, Cegedim, 2012
Cynthia LaConte, Dohmen Life
Science Services, 2015
Mary Lacquaniti, Healthcare
Communication & Marketing
Association, 2008
Mark Lacy, Benchmark Research,
2011
Michael Laferrera, Barrier
Therapeutics Inc., 2008
Betsy Lahue, Becton, Dickinson and
Company, 2012
Sanjit Singh Lamba,MD, Eisai
Pharmatechnology, 2012, 2015
Alex Lancksweert, GlaxoSmithKline,
2011
Mark Landy, DDS, MIV Therapeutics
Inc., 2008
Jim Langford, DataLabs Inc., 2006
Robert Lanza, M.D., Advanced Cell
Technology Inc, 2007
Todd LaRoche, Palio, 2012
Stefan Larsson, The Boston
Consulting Group, 2013
Rob Laurens, BBK Worldwide, 2007
Ted Lawrence, Lawrence & Company,
2009
Jessica Lea, Tria Health, 2013
John Lechleiter, Ph.D., Eli Lilly and
Company, 2011
Doreen Lechner, Ph.D., Sentrx, a part
of Telerx, 2013
Eugene Lee, Communications Media
Inc, 2014
Jorge Lee, Questcor Pharmaceuticals,
2013
Philip Lee, PHT, 2011
Michael Lehmann, Patheon, 2013
Chitra Lele, Ph.D., Sciformix, 2014
Michael Leonetti, Boehringer
Ingelheim Pharmaceuticals Inc,
2008
Guillaume Leroy, Sanofi Pasteur, 2015
Patricia Leuchten, The Avoca Group,
2011
Ilyssa Levins, Center for
Communication Compliance, 2012
Arthur Levinson, Ph.D., Genentech,
2006
Kimberly Levy, MicroMass
Communications, 2009
Warren Levy, Ph.D., Unigene
Laboratories, 2010
R.J. Lewis, eHealthcare Solutions,
2013
Freda Lewis-Hall, M.D., Pfizer, 2011,
2014, and 2015 Red Jacket
Zorba Lieberman, Citeline Inc., 2008
Mary Ann Liebert, Mary Ann Liebert
Inc. publishers, 2005
Rob Likoff, Group DCA, 2010
Patrick Lindsay, United BioSource
Corp., 2007
Laura Liotta, Sam Brown Inc., 2015
Craig Lipset, Pfizer, 2010
Jeffrey Litwin, M.D., eResearch
Technology, 2012
Marlene Llopiz, M.D., Venn Life
Sciences, 2010, 2011
Antony Loebel, Sunovion
Pharmaceuticals, 2013
Brian Loew, Inspire, 2014
Evan Loh, M.D., Wyeth Research,
2008
Margaret Long, Astellas Pharma US,
2010
Brian Longo, Veeva, 2013
Sandra R. Lottes, PharmD, United
BioSource Corporation, 2015
Cheryl Lubbert, Health Perspectives
Group, 2015
Mike Luby, TargetRx Inc., 2006
Gregory Lucier, Invitrogen Corp., 2007
Jan Lundberg, M.B., Ph.D.,
AstraZeneca, 2006
Nancy Lurker, ImpactRx, 2005
Kevin Lustig, Ph.D., Assay Depot,
2012, 2013
Laura Marsh Lynner, Scientific Voice,
2008
Robert Lyons, Ph.D., Nextrials Inc,
2005
M
Geoff MacKay, Organogenesis, 2006,
2007
Alan MacKenzie, TAP Pharmaceutical
Products, 2005
Kathy Magnuson, Brand Pharm, 2008
Ibrahaim Mahmood, DrugDev, 2014
William Maichle, Kowa
Pharmaceuticals America Inc, 2009
Lukas Makris, Ph.D., BioCor, 2005
Tonya Mallory, Health Diagnostic
Laboratory, 2014
Sarah Mandracchia, BBK Worldwide,
2015
Melissa Manice, Cohero Health, 2015
Alfred Mann, MannKind, 2010
Abby Mansfield, Topin & Associates,
2012
S. Machelle Manuel, Ph.D., Sankyo
Pharma Inc., 2005
John Maraganore, Ph.D., Alnylam
Pharmaceuticals, 2009
Dominic Marasco, Innovex Inc., 2009
Michael Marcarelli, Pharm.D., FDA,
2010
Peter Marchesini, inVentiv Health,
2009
Mauricha Marcussen, Agano
Solutions/Auditgraph, 2013
Barbara Marino, Ph.D., PHT Corp.,
2010
JeanMarie Markham, Clinlogix, 2007
Brian Markison, King
Pharmaceuticals, 2006
Michelle Marlborough, Medidata
Solutions Worldwide, 2014
Dena Marrinucci, Epic Sciences, 2015
Stacy Mamarkos Martin,
Metropolitan Research Associates,
2005
Joseph Martinez, Amylin
Pharmaceuticals, 2009, 2012
Mario Martinez II, 360 Vantage, 2012
Bob Mason, Palio, 2008
Guy Mastrion, Palio Communications,
2006
Patrice Matchaba, M.D., Novartis,
2012
Neil Matheson, AXIS Healthcare,
2005
Howard Mayer, M.D., EMD Serono,
2011
Sylvia McBrinn, Vernalis
Pharmaceuticals Inc., 2007
Sir Allen McClay, Almac Group, 2011
Tim McCort, inVentiv, GSW, 2013
Philip McCrea, ClearPoint, 2011
Mark McDowell, Wishbone/ITP Inc.,
2006
Bill McEllen, Echo Torre Lazur, 2010
PHARMAVOICE 100 CELEBRATION
39
Celebration
PHARMAVOICE 100 HONOREES
THROUGH THE YEARS
Andrea McGonigle, Microsoft, 2013,
2014
Nadine McGowan, The Snow
Companies, 2011
Jack McKenzie, Ph.D., Mini Mitter, a
Philips Respironics company, 2009
Michael McLaughlin, M.D., Peloton
Advantage, 2009
Chuck McLeester, Roska Healthcare
Advertising, 2012
Kevin McMurtry, Advanced Health
Media, 2005, 2006
Matt McNally, Publicis Health Media,
2014, 2015
Robert McNally, Ph.D., GeoVax, 2010
Bill Meisle, GlaxoSmithKline, 2009
Mary Melia, Shaw & Todd Inc, 2006
Renee Mellas, Wishbone/ITP, 2008
John Mendlein, Ph.D., Atyr Pharma,
2013
Boaz Mendzelevski, M.D., BioClinica,
2014
Mike Menta, Campbell Alliance, an
inVentiv Health Company, 2015
James Mercante, TGaS Advisors,
2011
Lars Merk, Johnson & Johnson, 2011
Abbey Meyers, National Organization
for Rare Diseases Inc, 2007
Angela Miccoli, Cegedim Dendrite,
2010
Steven Michaelson, Wishbone/ITP
Inc., 2006, 2015
Susan Miller Viray, The
CementWorks, 2007
Diego Miralles, M.D., Janssen
Research & Development, 2012
Jules Mitchel, Ph.D., Target Health
Inc., 2014, 2015
DJ Mitsch, Pyramid Resource Group,
2013
Ed Mitzen, Palio Communications,
2005
Elizabeth Moench, MediciGroup Inc.,
2005
Ann Mohamadi, PwC, 2013
Paulash Mohsen, Pfizer, 2010
Olivia Montaño-Tritz, SynteractHCR,
2012
Hussain Mooraj, AMR Research, 2009
Michael Morales, Dimensional
Healthcare, 2005
Paulo Moreira, EMD Serono, 2015
Ellen Morgan, Synteract, 2009
Joel Morganroth, M.D., eResearch
Technology, 2010
Jeff Morhet, InNexus Biotechnology
Inc., 2008
Joy Morrell, The Therapeutics
Institute, a division of Ventiv
Commercial Services, 2005
Rick Morrison, Comprehend Systems,
2012
40
David Mott, MedImmune Inc., 2005,
2008
Wilhelm Muehlhausen, iCON Plc, 2015
Kurt Mueller, Roska Healthcare
Advertising, 2011
Keeshia Muhammad, Teva’s Women
Health, 2011
Edmundo Muniz, M.D., Ph.D., Certara,
2015
Ciaran Murray, ICON, 2014
Theresa Kane Musser, Rigel
Pharmaceuticals Inc., 2005
Kelly Myers, Qforma Inc., 2007
Laurie Myers, Ph.D., Fair Isaac Corp.,
2007
Michael Myers, Palio
Communications, 2007
N
Mario Nacinovich Jr., AXON US,
2005, 2011
Francois Nader, M.D., NPS
Pharmaceuticals, 2009
Nader Naeymi-Rad, Campbell
Alliance, 2009
Ramin Najafi, Ph.D., NovaBay
Pharmaceuticals Inc., 2008
Gail Naughton, Ph.D., Histogen, 2011
Stephen Neale, AbelsonTaylor, 2008
Marcee Nelson, Pink Tank, 2010
Andrew Newbigging, Medidata
Solutions Worldwide, 2011
Roger Newton, Ph.D., Esperion
Therapeutics, 2006
Graham Nicholls, Almac Clinical
Technologies, 2012
Lance Nickens, The Patient
Recruitment Agency, 2011
Jan Nielsen, Sonexus Health, 2014
Timothy Noffke, Integrated Project
Management Company Inc., 2007
Robert Norris, Complete Healthcare
Communications, 2009
John Nosta, NostaLab, 2015
Tina Nova, Ph.D., Genoptix, a Novartis
company, 2012
O
Michael O’Connell, Ph.D., Insightful
Corp., 2005
Lelia O’Connor, Ngal So Authentic
Leadership Group, 2008
Francis O’Donnell Jr., M.D., Accentia
Biopharmaceuticals, 2007
Michael O’Gorman, Sentrx, a part of
Telerx, 2013
Jeanine O’Kane, Biosector 2, inVentiv,
2015
Jim Ogle, INC Research, 2012
Thomas Okarma, Ph.D., M.D., Geron
Corp., 2006
Nosa Omoigui, Nervana Inc., 2006
Alan Ong, INC Research, 2015
PHARMAVOICE 100 CELEBRATION
Paul Orhii, M.D., Ph.D., Nigerian
NAFDAC, 2010
John Orloff, M.D., Baxter BioScience,
2015
David Ormesher, closerlook, 2010,
2011, 2013, and 2014 Red Jacket
Susan Orr, O.D., Alcon Inc., 2005
P
Nigel Page, i3, 2007
Tim Pantello, PwC, 2015
Darlene Panzitta, DSP Clinical
Research, 2012
Michael Parisi, Ogilvy CommonHealth,
2012
Steve Parker Jr., Solos Health LLC,
2007
Julian Parreño, Harte-Hanks, 2008
Cindy Parrott, Community Health
Systems, 2012
Vince Parry, Y Brand, 2010
Georgette Pascale, Pascale
Communications LLC, 2009
David Passov, ClinStar, 2011
David Pasta, ICON Clinical Research,
2009
Nikin Patel, Molecular Profiles Ltd.,
2011
Yvonne Paterson, Ph.D., University of
Pennsylvania / Advaxis Inc., 2014
Philip Patrick, PharmaStrat Inc., 2005
Tiffany Patrick, Clinical Practice
Insights, 2011
Kristin Patton, HealthEd Group, 2008
Jean Paty, Ph.D., invivodata Inc, 2007
Robert Paull, Lux Capital
Management, 2010
Devin Paullin, Physicians Interactive,
2010
Krista Payne, United BioSource Corp.,
2014
Stuart Peltz, Ph.D., PTC Therapeutics,
2009, 2015
Edward Penhoet, Ph.D., Alta Partners,
2005
Javier Revuelta Pérez, Ph.D.,
Pharm.D., INC Research, 2011
Chris Perkin, Algorithme Pharma,
2015
Adelene Perkins, Infinity
Pharmaceuticals, 2012
Susan Perlbachs, GSW, 2014
Dan Perlman, RPS, 2013
Jennifer Peters, Greenphire, 2015
Robert Peters, MicroMass
Communications, 2012
Kenneth Phelps, Camargo
Pharmaceutical Services, 2009
Donald Phillips, Pharm.D., Vox
Medica, 2008
Jack Phillips, Roche Diagnostics, 2012
Kristin LaBounty Phillips, The Patient
Experience Project, 2015
Marci Piasecki, Torre Lazur McCann,
2007
Richard Piazza, Pharm.D, etrials
Worldwide Inc., 2006
Joe Pieroni, Daiichi Sankyo, 2010
Christine Pierre, Rx Trials and Society
for Clinical Research Sites, 2009,
2013
Michael Pietrack, TMAC Direct, 2015
Art Pirrone, Modular Thermal
Thechnologies, 2013
Robert Piwko, C3i, 2010
Michael Platt, Fission
Communications, 2006
Scott Plevy, M.D., Janssen Research
& Development, LLC, one of the
Janssen Pharmaceutical Companies
of Johnson & Johnson, 2015
Bill Pollock, Pharmagistics Group,
2008
Stephen Pomeranz, M.D., ProScan
Imaging and ProScan Educational
Foundation, 2007
Timothy Poole, Pharm.D., Pfizer, 2007
Christine Poon, Johnson & Johnson,
2006
Chris Porter, Clinipace Inc, 2008
Jack Porter, DecisionView Software,
2006
Miranda Pothiawala, Samarind Ltd.,
2014
Frank Powers, Dudnyk, 2011
James Powers, HemoShear, 2014
Timothy Pratt, Ph.D., MedNet
Solutions, 2005
Sharon Presnell, Organovo, 2013
Robert Previdi, PSKW, 2012, 2013,
2014
Beth Anne Price, The Medical Affairs
Company, 2007, 2015
Philip Priest, GlaxoSmithKline, 2011
Josh Prince, The CDM Group, 2012
Barbara Pritchard, The Pritchard
Group, 2005
Anna Protopapas, Millennium
Pharmaceuticals, 2014
Charlene Prounis, FlashPoint Medica,
2005
Ahnal Purohit, Ph.D., Purohit
Navigation, 2009, 2010
James Pusey, M.D., Omnicare Clinical
Research, 2010
Andy Pyfer, Fingerpaint, 2015
Q
Patricia Quilty, Archives of Internal
Medicine and Archives of
Dermatology, 2006
R
John Racik, Stonefly Communications
Group, 2008
George Rafols, PharmaLinkFHI, 2006
Celebration
Julia Ralston, MedErgy HealthGroup,
2007
Sumant Ramachandra, M.D., Ph.D.,
Hospira Inc., 2011
Donna Ramer, StrategCations Inc, 2009
Kim Ramko, Ernst & Young, 2013
Laura Randa, GlaxoSmithKline, 2013
Ken Rapp, Accelrys, 2013
Ramesh Raskar, MIT Media Lab, 2013
Pam Rattananont Ferris, Core
Principle Solutions, 2011
Amrit Ray, M.D., Pfizer, 2005
Stephen Raymond, Ph.D., PHT, 2006
Mike Rea, IDEA Pharma, 2011, 2013,
2015
David Rear, R.Ph., Advanced Clinical
Concepts, 2013
Robert Rebak, QualityHealth, 2011
Dana Reeve, Christopher Reeve
Foundation, 2006
Maureen Regan, Regan Campbell
Ward, 2006
Alan Reicheg, Qforma, 2010
Clifford Reid, Ph.D., Complete
Genomic, 2010
Elizabeth Reid, Duke Clinical Research
Insitute, 2011
Patrick Revelle, MedDRA MSSO, 2008
Ken Ribotsky, Brandkarma, 2014
Katrina Rice, eClinical Solutions, 2011
Linda Richardson, Reliant
Pharmaceuticals, 2008
Scott Richardson, Pfizer, 2012
Melinda Richter, Johnson & Johnson,
2015
Elaine Riddell, TNS Healthcare, 2008
Zack Rinat, Model N, 2005
Jamie Ring, Genzyme, 2013
Tobias Ritter, Ph.D., SciFluor Life
Sciences, 2012
Alessandro Riva, Novartis AG, 2014
Adrienne Robinson, Merck, 2013
Harriet Robinson, Ph.D., GeoVax, 2011
Jim Robinson, Astellas Pharma US,
Inc., 2015
Sheila Rocchio, PHT, 2012
James Rogers, Nextrials Inc., 2007
Mary Rose Rogowski, PulseCX,
2015
Michelle Rohrer, Ph.D., Genentech,
2014
Bruce Rooke, GSW, 2010
Linda Rosenes, Pfizer, 2012
Allen David Roses, M.D.,
GlaxoSmithKline, 2005
Lorin Roskos, Ph.D., Abgenix, 2005
Julie Ross, Advanced Clinical LLC,
2014
Duane Roth, Connect, 2014
William Roth, Blue Fin Group, 2008
Karen Roy, Phlexglobal, 2014
Maryellen Royle, Tonic Life
Communications, 2015
Sydney Rubin, inVentiv Health, 2014
Darielle Ruderman, GlaxoSmithKline,
2011
Robert Ruffolo Jr., Ph.D., Wyeth, 2005
Nancy Ruiz, M.D., Meda
Pharmaceuticals, 2014
Vera Rulon, Pfizer, Inc., 2015
Angus Russell, Shire Pharmaceuticals,
2009
Chan Russell, Lincoln Technologies/
Phase Forward, 2007
Richard Russell, Sunovion
Pharmaceuticals, 2013
Mike Rutstein, DraftFCB NY, 2008,
2012
John Ryals, Ph.D., Metabolon Inc,
2005
Una Ryan, Ph.D., Diagnostics for All,
2010
S
Ryan Saadi, M.D., Johnson &
Johnson, 2011, 2015
Helen Sabzevari, Ph.D., EMD Serono,
2013
Dinah Sah, M.D., Voyager
Therapeutics, 2014
M. Scott Salka, Ambit Biosciences,
2006
Dr. Niranjan Y. Sardesai, Inovio
Pharmaceuticals, 2015
Brent Saunders, Schering-Plough
Corp., 2009
George Savage, M.D., Proteus Digital
Health, 2014
James Sawyer, MBChB, Prism Ideas,
2011
Adriann Sax, King Pharmaceuticals
Inc., 2008
George Scangos, Ph.D., Exelixis Inc.,
2006
Don Schenker, Synergistix, 2008,
2009, 2011
Barry Schmader, Dudnyk, 2009
Dan Schneider, Consultant, 2009
Laurent Schockmel, DVM, Cegedim
Dendrite, 2009
Anne Faulkner Schoemaker, Neuronyx
Inc., 2007
James Schoeneck, BrainCells Inc.,
2008
Peter Scholes, Ph.D., Quotient
Bioresearch, 2010
Chris Schroeder, The HealthCentral
Network, 2008, 2009
Lawrence H. Schwartz, M.D.,
Memorial Sloan-Kettering Cancer
Center, 2005
Fatima Scipione, Millennium
Pharmaceuticals, 2013
Kevin Scott, Johnson & Johnson,
2010
Dr. Theodore Search, Skipta, 2015
Alex Sefanov, Perficient Inc., 2014
Leerom Segal, Klick Health, 2012,
2013, 2014, and 2015 Red Jacket
David Segarnick, MedEvoke, 2013
Ed Seguine, Clinical Ink, 2012
Karen Seibert, Ph.D., Pfizer Global
Research and Development, 2008
Stephen F. Sener, M.D., American
Cancer Society, 2005
Emma Sergeant, Fast4wD Ogilvy,
2009
Susan Seroskie, Advanced Clinical
LLC, 2014
Satwik Seshasai, NextDocs, 2013
Rachel Sexton, VPR Patient Outreach
Program, 2014
Lecia Shaffer, Nextrials Inc., 2009
Sandeep Shah, Skyscape Inc., 2008
Kabir Shahani, Appature, 2012
Kevin Sharer, Amgen, 2006
Christi Shaw, Novartis AG, 2015
Duncan Shaw, MediciGlobal, 2011
Paul Shawah, Veeva, 2012
Lauren Shawver, Ph.D., Cleave
Biosciences, 2012
Lori Shields, Medidata Solutions
Worldwide, 2009
Kirk Shepard, Baxter Healthcare, 2015
Todd Sherer, Ph.D., The Michael J.
Fox Foundation for Parkinson’s
Research, 2012
Leo Sheridan, Advanced Clinical, 2015
Tarek Sherif, Medidata Solutions
Worldwide, 2007
Adam Sherlock, CSC, 2012
Nicolette Sherman, Sanofi, 2014
Blake Shewey, Snow Companies,
2015
Joe Shields, Pfizer, 2010
Mollie Shields-Uehling, SAFEBioPharma Association, 2008
Martin Shkreli, Retrophin, 2013
Kuslima Shogen, Alfacell, 2005
Ken Shore, Blue Chip Patient
Recruitment, 2014
Charlotte Sibley, Shire
Pharmaceuticals, 2006
Jay Philip Siegel, M.D., Janssen
Research & Development, 2012
Peter Siegel, The Hal Lewis Group,
2007
Michael Simone, The Snow
Companies, 2011
Graham Simpson, GlaxoSmithKline,
2013
Raman Singh, Mundipharma, 2014
Marc Sirockman, Artcraft Health,
2013, 2015
Albert Siu, PAREXEL, 2015
Dan Skovronsky, M.D., Ph.D., Avid
Radiopharmaceuticals, 2007
Todd Skrinar, EY, 2014
Tim Slevin, Veeva Systems, 2015
Nancy Smerkanich, Octagon Research
Solutions Inc., 2005
Andy Smith, Palio, 2009
Christine Smith, Pfizer Global
Research and Development, 2007
Dorothy Smith, Pharm.D., Consumer
Health Information Corp., 2008
Peter Smith, Ph.D, Millennium: The
Takeda Oncology Co., 2009
Stephen Smith, Medidata Solutions,
2015
Brenda Snow, The Snow Companies,
2007, 2010
Mike Soenen, ClearTrial, 2010
Martin Soeters, Novo Nordisk, 2005,
2007
Jean-Pierre Sommadossi, Ph.D.,
Pharm.D., Idenix Pharmaceuticals,
2005
Donald Soong, Cegedim Relationship
Management, 2014
Craig Sorensen, Ph.D., Vertex
Pharmaceuticals, 2010
Rodney Spady, Novartis Consumer
Health Inc., 2008
Jeff Spanbauer, Healthcare Regional
Marketing, 2012
Ira Spector, Wyeth Pharmaceuticals,
2007
Shelley Spencer, Total Learning
Concepts and Arista Marketing,
2007
John Spitznagel, Oceana
Therapeutics, 2006, 2010
Badhri Srinivasan, Quintiles, 2014
Nagarajan Srivatsan, Cognizant, 2010
Andrew Stanger, GenR Media, 2012
Larry Star, Harrison & Star, 2005, 2010
Joseph Stauffer, D.O, Alpharma, 2007
Abbe Steel, United BioSource Corp.,
2013
Jeffrey Stein, Ph.D., Trius
Therapeutics, 2009
Susan Stein, Connexion Healthcare,
2005
Howard Steinberg, dLife – For Your
Diabetes Life!, 2008
Annette Stemhagen, Dr.PH., United
BioSource Corp., 2011
Keith Stenlund, AbelsonTaylor, 2015
Hugo Stephenson, M.D., iGuard.org, a
Quintiles Co., 2010
David Stern, Serono, 2005
Robert Stern, Projects In Knowledge,
2009
Dr. Leo H. Sternbach, Roche, 2005
Betsy Brown Stewart, Trio Clinical
Research, 2007, 2012
Mark Stinson, Stinson Brand
Innovation Inc., 2009
Robert Stirling, McNeil Consumer
Healthcare, 2007
Kim Stratton, Novartis AG, 2011
PHARMAVOICE 100 CELEBRATION
41
Celebration
PHARMAVOICE 100 HONOREES
THROUGH THE YEARS
Pam Strobel, inVentiv Health Clinical,
2013
William (Bill) R. Strohl, Ph.D., Janssen
Research & Development, LLC,
one of the Janssen Pharmaceutical
Companies of Johnson & Johnson,
2015
Peter Strumph, Nile Therapeutics
Inc., 2008
Matthew Stumm, BBK Worldwide,
2013
Anish Suri, Ph.D., Janssen Research
& Development, LLC, one of the
Janssen Pharmaceutical Companies
of Johnson & Johnson, 2015
Danita Sutton, Ph.D., MedErgy
HealthGroup, 2008
Robert Swanson, Genentech, 2005
Steve Swanson, Imperial, 2013
Jeff Sweeney, Regan Campbell Ward
Group, 2011
Rita Sweeney, Dorland Global Corp,
2006
Judy Swilley, Ph.D., INC Research,
2014
Zikria Syed, NextDocs Corp., 2007
Maryann Szabo, Roche, 2010
Ana Szarfman, M.D., Ph.D., U.S. Food
and Drug Administration, 2007
Kenneth Tomaszewski, Ph.D., KJT
Group, 2012
Joseph Tonning, M.D., M.P.H., R.Ph.,
Food and Drug Administration, 2008
Alan Topin, Topin & Associates,
2009
Terrence Tormey, BrandParents, 2005
Susan Torroella, Columbia MedCom
Group, 2005
Donato Tramuto, Physicians
Interactive, 2005, 2009, 2012, and
2014 Red Jacket
Lois Trench-Hines, Meniscus Ltd,
2005
Chris Trizna, CSSi, 2014
Jeff Trotter, PharmaNet, 2010
Nancy Mensch Turett, Edelman, 2007
T
V
Bill Taaffe, ICON, 2011
Leonard Tacconi, Discovery Health,
2007
John Talanca Jr., Novartis, 2006
Francis Tally, M.D., Cubist
Pharmaceuticals Inc., 2006
Nobuhiko Tamura, Sunovion, 2011
Jeff Tangney, Epocrates, 2007
Alison Taunton-Rigby, Ph.D., O.B.E.,
RiboNovix Inc., 2006
Dale Taylor, AbelsonTaylor, 2005
Jeff Taylor, Columbia MedCom Group,
2007
David Templeton, Enzon
Pharmaceuticals, 2007
Angela Tenuta, Intouch Solutions,
2014
Robert Teoh, M.D., i3 Research, 2008
Joe Tetzlaff, i3, 2009
Kent Thoelke, PRA, 2013
Brad Thompson, Ph.D., Oncolytics
Biotech Inc, 2005, 2006
David S. Tierney, M.D., Oceana
Therapeutics., 2005, 2006, 2011
Victoria Tifft, CRM and M3 Clinical
Research, 2007
Uwe Tigör, M.D., Palio, 2011
Mark Timney, Purdue Pharma, 2015
Sreedhar Tirunagari, M.D.,
MakroCare Clinical Research, 2012
Christopher Tobias, Ph.D., Dudnyk,
2012
42
U
Jay Udani, M.D., Medicus Research/
SysteMedicus, 2013
Henrietta Ukwu, M.D., PPD, 2011
Pablo Umaña, Ph.D., Roche GlycArt,
2014
Shaun Urban, Solara and Valos, part
of CommonHealth, 2009
Dennis Urbaniak, Sanofi, 2011
Kathy Jo Usher, Bayer Healthcare
Dermatology, 2013
Marco van Doeveren, Medidata
Solutions Worldwide, 2012
Fredrick Van Goor, Ph.D., Vertex
Pharmaceuticals, 2011
Richard Vanderveer, Ph.D., GfK,
2005
Ken VanLuvanee, Virtual Regulatory
Solutions, 2014
Martin VanTrieste, R.Ph., Amgen,
2012
Daniel Vasella, M.D., Novartis, 2005,
2006, 2009
Vikas Vats, marketRx, 2007
Tristan Vaughan, Ph.D., MedImmune,
2011
Leonard J. Vicciardo, inVentiv Pharma
Analytics, 2006
Chris Viehbacher, Sanofi-Aventis,
2010, 2011
Dr. Brad Vince, Vince and Associates
Clinical Research, 2015
L. Stephan Vincze, TAP
Pharmaceutical Products Inc, 2007
Dr. Giulio Vita, Bristol-Myers Squibb,
2005
Steve Viviano, ICC Lowe, 2012
Polina Voloshko, M.D., Gentiae, 2006
Darik Volpa, Understand.com, 2013
Alexandra von Plato, Publicis
Healthcare Communications, 2013
Josef von Rickenbach, Parexel
International Corp., 2007
PHARMAVOICE 100 CELEBRATION
Lynn O’Connor Vos, Grey Healthcare
Group, 2005
Ruth Vukelich, PLEXUS Learning
Designs Inc., 2005
Saru Wade, Vertex Pharmaceuticals,
2012
W
Ronald Waife, Waife & Associates
Inc., 2008
Tim Walbert, Horizon Pharma, 2010,
2015
James Walker, Octagon Research
Solutions, 2010
Steven Walker, MedImmune, 2012
Jon Wallace, CV Therapeutics, 2005
Matt Wallach, Verticals onDemand
Inc., 2007
Neill “Gobie” Walsdorf, Jr., Mission
Pharmacal Company, 2015
Meg Walsh, CommonHealth, 2008
Blane Walter, inChord
Communications, 2005
Anna Walz, Medisys Health
Communications, 2012
Brendan Ward, Regan Campbell
Ward, 2009
Gail Wasserman, Ph.D., MedImmune,
2011
Scott Watson, Ogilvy CommonHealth,
2010
Bob Weiler, Phase Forward, 2006
Marc Weiner, Ogilvy CommonHealth
Worldwide, 2013
Michael Weintraub, Humedica, 2010
Scott Weintraub, Healthcare Regional
Marketing, 2011
Howard Weisman, EKR Therapeutics
Inc., 2008
Neil Weisman, Blue Chip Healthcare
Marketing, 2011
Carol Wells, Genentech, 2010
Jean-Pierre Wery, Ph.D., Crown
Bioscience Inc., 2014, 2015
Matthew West, Regan Campbell
Ward, 2013
Christoph Westphal, M.D., Ph.D.,
Sirtris Pharmaceuticals Inc., 2008
Sarah Wharmby, Bristol-Myers
Squibb, 2011
Carl Whatley, ProEthic
Pharmaceuticals Inc., 2008
Mark Wheeldon, Formedix, 2014
Samuel Whitaker, Greenphire, 2013
John White, R.Ph., The Medical
Affairs Company, 2014
Ted White, Novartis, 2010
Wendy White, Dohmen Lfie Science
Services, 2012, 2015
Thomas Wicks, TrialScope, 2015
Sarah Wilcox, Draft Health Inc., 2006
Nila Williams, Clinsys Clinical
Research Inc., 2008
Jeffrey Williams, Clinipace, 2007
Leslie Williams, Ventaira
Pharmaceuticals, 2006
Engelbert Tjeenk Willink,
M.D., Boehringer Ingelheim
Pharmaceuticals Inc, 2009
Mark Willmann, Torre Lazur McCann,
2011
Renee Wills, ICC Lowe Trio, 2013
Glynn WIlson, TapImmune, 2015
Zane Wilson, The South African
Depression and Anxiety Group,
2007
Jeff Wiltrout, Ph.D., GlaxoSmithKline,
2006
Robin L. Winter-Sperry, M.D.,
Scientific Advantage LLC, 2005,
2013
Andrew Witty, GlaxoSmithKline, 2009
Janet Wolfe, Ph.D., Wolfe
Laboratories, 2010
Corbin Wood, Snow Companies,
2014
David Wood, Interbrand Wood
Healthcare, 2005
Deborah Wood, DWA Healthcare
Communications Group, 2010, 2015
Nicole Woodland, compas, inc.,
2015
Stan Woodland, CMI and Compas
Inc., 2008
Stephen Wray, Cadient Group, 2012
Larry Wright, Ph.D., MedErgy
HealthGroup, 2009
Timothy Wright, M.D., Novartis, 2012
Sandra Wrobel, Applied Strategies
Consulting Inc., 2007
Stanley Wulf, M.D., InfoMedics, 2009
Graham Wylie, MBBS, The Medical
Research Network, 2014
Rachael Wyllie, CRF Health, 2015
Nancy Wysenski, EMD
Pharmaceuticals, 2006
André Wyss, Novartis, 2013
Y
Rosemarie Yancosek, ScheringPlough Corp., 2007
Natalie Yeadon, Genentech, 2007
Lihua Yu, H3Biomedicine, 2015
Z
Christine Zak, DAS-Omnicom, 2006,
2015
David Zaritsky, Roska Healthcare,
2006, 2013
Meryl Zausner, Novartis, 2014
Silvia Zieher, M.D., INC Research,
2010
Howard Ziment, Ziment Group, 2006
Jeanne Zucker, InfoMedics Inc, 2008
Andrew Zupnick, Novella Clinical,
2015
ALEXANDRIA CENTER® FOR
LIFE SCIENCE – NEW YORK CITY
New York City’s first and only urban science and technology campus,
providing a dynamic, creative, and collaborative office/laboratory
environment for leading science and technology companies
at the forefront of innovation.
Alexandria Real Estate Equities, Inc. | www.are.com
WE MAKE LIFE CHANGING PLACEMENTS
SO OUR CLIENTS CAN CHANGE LIVES!®
benchinternational.com